{"total":4930,"currentPage":48,"resultsPerPage":60,"numberOfPages":83,"instruments":[{"id":"31033cf0-c1a3-4ce8-b09f-7d27bce59110","urlSlug":"nyse-kodk","instrumentType":"equity","symbol":"KODK","kidsRecommended":false,"isVolatile":false,"name":"Eastman Kodak Co.","description":"Eastman Kodak Company is a global commercial printing and imaging company with technologies in materials science, digital imaging science and software, and deposition processes. The Company provides hardware, software, consumables and services to customers in graphic arts, commercial print, publishing, packaging, electronic displays, entertainment and commercial films, and consumer products markets. The Company operates through seven segments: Print Systems, Micro 3D Printing and Packaging, Software and Solutions, Consumer and Film, Enterprise Inkjet Systems, Advanced Materials and 3D Printing Technology and Eastman Business Park. The Print Systems segment comprises two lines of business: Prepress Solutions and Electrophotographic Printing Solutions. The Micro 3D Printing and Packaging segment comprises two lines of business: Packaging and Micro 3D Printing.","categories":["Manufacturing","Technology"],"logoIdentifier":"b0f904a4-ba0d-4d17-814d-8e783397f0d3","logos":{"wide":"/api/v1/public/instrument-logo/31033cf0-c1a3-4ce8-b09f-7d27bce59110/logo/b0f904a4-ba0d-4d17-814d-8e783397f0d3/1024/0","thumb":"/api/v1/public/instrument-logo/31033cf0-c1a3-4ce8-b09f-7d27bce59110/logo/b0f904a4-ba0d-4d17-814d-8e783397f0d3/342/0","micro":"/api/v1/public/instrument-logo/31033cf0-c1a3-4ce8-b09f-7d27bce59110/logo/b0f904a4-ba0d-4d17-814d-8e783397f0d3/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.96","percent":"-0.09826","max":"9.77","min":"8.81"},"1m":{"value":"2.06","percent":"0.305185","max":"11.05","min":"6.48"},"3m":{"value":"0.06","percent":"0.006857","max":"11.05","min":"6.44"},"6m":{"value":"-0.53","percent":"-0.056745","max":"12.08","min":"6.44"},"1y":{"value":"6.37","percent":"2.610656","max":"33.2","min":"2.02"},"5y":{"value":"-6.81","percent":"-0.43598","max":"33.2","min":"1.55"}},"marketPrice":"8.81","marketLastCheck":"2021-06-15T19:59:58Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":691615624,"websiteUrl":"www.kodak.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#E7AA71","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"2.610656","ceo":"","employees":4922},{"id":"b4dc1373-dec1-4114-a870-cb061b0ebf9f","urlSlug":"nasdaq-oric","instrumentType":"equity","symbol":"ORIC","kidsRecommended":false,"isVolatile":false,"name":"ORIC Pharmaceuticals","description":"ORIC Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on improving patients’ lives by overcoming resistance in cancer. The Company is focused on developing a diverse pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its experience within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. Its lead product candidate is ORIC-101. The Company’s ORIC-101 is a potent and selective small-molecule antagonist of the glucocorticoid receptor (GR), which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. The Company’s second product candidate, ORIC-533, is an orally bioavailable, small-molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy-and immunotherapy-based treatment regimens. Its third product candidate, ORIC-944, being developed for prostate cancer.","categories":["Healthcare","Manufacturing"],"logoIdentifier":"8253ae84-c0fa-412b-befa-c9e49d7e3ad0","logos":{"wide":"/api/v1/public/instrument-logo/b4dc1373-dec1-4114-a870-cb061b0ebf9f/logo/8253ae84-c0fa-412b-befa-c9e49d7e3ad0/1024/0","thumb":"/api/v1/public/instrument-logo/b4dc1373-dec1-4114-a870-cb061b0ebf9f/logo/8253ae84-c0fa-412b-befa-c9e49d7e3ad0/342/0","micro":"/api/v1/public/instrument-logo/b4dc1373-dec1-4114-a870-cb061b0ebf9f/logo/8253ae84-c0fa-412b-befa-c9e49d7e3ad0/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.025","percent":"0.00133","max":"0","min":"0"},"1w":{"value":"-0.775","percent":"-0.039541","max":"19.95","min":"18.8"},"1m":{"value":"-6.515","percent":"-0.257103","max":"25.07","min":"18.8"},"3m":{"value":"-9.365","percent":"-0.33221","max":"28.81","min":"18.8"},"6m":{"value":"-16.565","percent":"-0.46807","max":"39.8","min":"18.8"},"1y":{"value":"-15.015","percent":"-0.443706","max":"39.8","min":"18.8"},"5y":null},"marketPrice":"18.825","marketLastCheck":"2021-06-15T19:59:56Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":690806266,"websiteUrl":"oricpharma.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#549184","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.443706","ceo":"Jacob Chacko","employees":88000},{"id":"ebf97d9a-2fcb-4f06-bdd8-26b8112e31b7","urlSlug":"scl","instrumentType":"equity","symbol":"SCL","kidsRecommended":false,"isVolatile":false,"name":"Scales Corporation","description":"Scales Corporation Limited is engaged in agribusiness. The Company's principal activities are to provide logistics services, grows apples, exports products, provide insurance services to companies within the Company, and operate storage and processing facilities. The Company's segments include Food Ingredients, which is engaged in processing and marketing of food ingredients, such as pet food ingredients and juice concentrate; Horticulture, which includes orchards, fruit packing and marketing; Storage & Logistics, which provides cool, cold and bulk liquid storage and logistics services, and Other, which includes the operations of Scales Corporation Limited, Scales Employees Limited, Scales Holdings Limited and Selacs Insurance Limited. Its Horticulture segment includes the operations of New Zealand Apple Limited and Longview Packhouse Limited. Its Food Ingredients segment includes the operations of Meateor Foods Limited, Meateor Foods Australia Pty Limited and Profruit (2006) Limited.","categories":["Agriculture and fisheries","Transport"],"logoIdentifier":"d6bda540-f5f5-4558-b198-544d4e0c59e3","logos":{"wide":"/api/v1/public/instrument-logo/ebf97d9a-2fcb-4f06-bdd8-26b8112e31b7/logo/d6bda540-f5f5-4558-b198-544d4e0c59e3/1024/0","thumb":"/api/v1/public/instrument-logo/ebf97d9a-2fcb-4f06-bdd8-26b8112e31b7/logo/d6bda540-f5f5-4558-b198-544d4e0c59e3/342/0","micro":"/api/v1/public/instrument-logo/ebf97d9a-2fcb-4f06-bdd8-26b8112e31b7/logo/d6bda540-f5f5-4558-b198-544d4e0c59e3/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.1","percent":"0.021053","max":"0","min":"0"},"1w":{"value":"0.02","percent":"0.004141","max":"4.85","min":"4.75"},"1m":{"value":"0.46","percent":"0.104784","max":"4.9","min":"4.52"},"3m":{"value":"0.4","percent":"0.089888","max":"4.9","min":"4.35"},"6m":{"value":"0.1","percent":"0.021053","max":"5.04","min":"4.26"},"1y":{"value":"-0.1","percent":"-0.020202","max":"5.27","min":"4.26"},"5y":{"value":"1.67","percent":"0.525157","max":"5.39","min":"2.9"}},"marketPrice":"4.85","marketLastCheck":"2021-06-16T04:22:08Z","tradingStatus":"active","exchangeCountry":"nzl","peRatio":"32.73","marketCap":690614959,"websiteUrl":null,"exchange":"NZX","legacyImageUrl":"/api/fund/7d54dcb70ed5439f040096499d97ee1a/ebf97d9a-2fcb-4f06-bdd8-26b8112e31b7/image/","dominantColour":"#26a48e","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.05567","annualisedReturnPercent":"0.035468","ceo":null,"employees":0},{"id":"c93c17ba-603f-460e-95eb-0ad1a81a5eac","urlSlug":"nasdaq-sppi","instrumentType":"equity","symbol":"SPPI","kidsRecommended":false,"isVolatile":false,"name":"Spectrum Pharmaceuticals, Inc.","description":"Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.","categories":["Healthcare","Manufacturing","Technology"],"logoIdentifier":"ff67e3f9-12cd-4ebe-81c3-82f93b134e81","logos":{"wide":"/api/v1/public/instrument-logo/c93c17ba-603f-460e-95eb-0ad1a81a5eac/logo/ff67e3f9-12cd-4ebe-81c3-82f93b134e81/1024/0","thumb":"/api/v1/public/instrument-logo/c93c17ba-603f-460e-95eb-0ad1a81a5eac/logo/ff67e3f9-12cd-4ebe-81c3-82f93b134e81/342/0","micro":"/api/v1/public/instrument-logo/c93c17ba-603f-460e-95eb-0ad1a81a5eac/logo/ff67e3f9-12cd-4ebe-81c3-82f93b134e81/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.005","percent":"0.001171","max":"0","min":"0"},"1w":{"value":"-0.065","percent":"-0.014977","max":"4.45","min":"4.27"},"1m":{"value":"0.795","percent":"0.228448","max":"4.45","min":"3.22"},"3m":{"value":"0.755","percent":"0.214489","max":"4.45","min":"2.89"},"6m":{"value":"-0.38","percent":"-0.081633","max":"4.655","min":"2.89"},"1y":{"value":"1.295","percent":"0.434564","max":"5.14","min":"2.89"},"5y":{"value":"-2.545","percent":"-0.373167","max":"24.82","min":"1.83"}},"marketPrice":"4.275","marketLastCheck":"2021-06-15T19:59:10Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":690500445,"websiteUrl":"www.sppirx.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#6C83B4","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.434564","ceo":"","employees":235},{"id":"34e00015-4ccc-4082-982c-990e4ccbfd36","urlSlug":"nyse-dgnr","instrumentType":"equity","symbol":"DGNR","kidsRecommended":false,"isVolatile":false,"name":"Dragoneer Growth Opportunities Corp.","description":"Dragoneer Growth Opportunities Corp. is a blank check company. The Company is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It focuses on software, Internet, media, consumer/retail, healthcare information technology (IT) and financial services/financial technology sectors. The Company has no business operations. The Company has no revenues.","categories":["Banking and finance"],"logoIdentifier":"91c151de-80dd-432e-84e4-37872c990864","logos":{"wide":"/api/v1/public/instrument-logo/34e00015-4ccc-4082-982c-990e4ccbfd36/logo/91c151de-80dd-432e-84e4-37872c990864/1024/0","thumb":"/api/v1/public/instrument-logo/34e00015-4ccc-4082-982c-990e4ccbfd36/logo/91c151de-80dd-432e-84e4-37872c990864/342/0","micro":"/api/v1/public/instrument-logo/34e00015-4ccc-4082-982c-990e4ccbfd36/logo/91c151de-80dd-432e-84e4-37872c990864/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.05","percent":"-0.004975","max":"10.09","min":"10.0"},"1m":{"value":"0.05","percent":"0.005025","max":"10.09","min":"9.91"},"3m":{"value":"-1.05","percent":"-0.095023","max":"11.07","min":"9.91"},"6m":{"value":"-3.2","percent":"-0.242424","max":"14.7","min":"9.91"},"1y":null,"5y":null},"marketPrice":"10.0","marketLastCheck":"2021-06-15T19:59:58Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":690000000,"websiteUrl":"www.dragoneergrowth.com/dgnr/","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#C2B1B4","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":null,"ceo":"","employees":0},{"id":"84e1e02b-33d0-4bdc-aaf5-76a4d23528bc","urlSlug":"nyse-csv","instrumentType":"equity","symbol":"CSV","kidsRecommended":false,"isVolatile":false,"name":"Carriage Services, Inc.","description":"Carriage Services, Inc. is a provider of death care services and merchandise in the United States. The Company operates in two business segments: Funeral Home Operations and Cemetery Operations. The Funeral Homes segment provides funeral services (traditional burial and cremation) and sells related merchandise, such as caskets and urns. Its cemetery products and services include interment services, the rights to interment in cemetery sites and related cemetery merchandise, such as memorials and vaults. It serves suburban and rural markets. It provides funeral and cemetery services and products on both at-need (time of death) and preneed (planned prior to death) basis. It also maintains trusts in connection with funeral home and cemetery operations, including preneed funeral trusts, preneed cemetery merchandise and service trusts and cemetery perpetual care trusts. The Company operates approximately 183 funeral homes in 29 states and 29 cemeteries in 11 states.","categories":["Services"],"logoIdentifier":"e044df1b-5a0d-449f-8fff-fc8ac52367d4","logos":{"wide":"/api/v1/public/instrument-logo/84e1e02b-33d0-4bdc-aaf5-76a4d23528bc/logo/e044df1b-5a0d-449f-8fff-fc8ac52367d4/1024/0","thumb":"/api/v1/public/instrument-logo/84e1e02b-33d0-4bdc-aaf5-76a4d23528bc/logo/e044df1b-5a0d-449f-8fff-fc8ac52367d4/342/0","micro":"/api/v1/public/instrument-logo/84e1e02b-33d0-4bdc-aaf5-76a4d23528bc/logo/e044df1b-5a0d-449f-8fff-fc8ac52367d4/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.000262","max":"0","min":"0"},"1w":{"value":"-0.5","percent":"-0.012913","max":"38.72","min":"37.74"},"1m":{"value":"0.17","percent":"0.004468","max":"38.78","min":"37.23"},"3m":{"value":"2.17","percent":"0.060194","max":"38.78","min":"34.65"},"6m":{"value":"9.17","percent":"0.315663","max":"38.78","min":"29.05"},"1y":{"value":"18.76","percent":"0.964029","max":"38.78","min":"17.11"},"5y":{"value":"15.4","percent":"0.674847","max":"38.78","min":"13.8"}},"marketPrice":"38.22","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"20.99","marketCap":689627606,"websiteUrl":"www.carriageservices.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#787965","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.010225392785156188","annualisedReturnPercent":"0.9742543927851562","ceo":"","employees":2797},{"id":"2e2443e6-27e8-414c-867d-4f456934172e","urlSlug":"nyse-rtp","instrumentType":"equity","symbol":"RTP","kidsRecommended":false,"isVolatile":false,"name":"Reinvent Technology Partners","description":"Reinvent Technology Partners is a blank check company. The Company is created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on target business operating in the consumer Internet, mobile gaming and technology sectors. The Company has no business operations and has no revenues.","categories":["Banking and finance"],"logoIdentifier":"4ff45c4c-d15f-4b51-bc0e-49e85260908c","logos":{"wide":"/api/v1/public/instrument-logo/2e2443e6-27e8-414c-867d-4f456934172e/logo/4ff45c4c-d15f-4b51-bc0e-49e85260908c/1024/0","thumb":"/api/v1/public/instrument-logo/2e2443e6-27e8-414c-867d-4f456934172e/logo/4ff45c4c-d15f-4b51-bc0e-49e85260908c/342/0","micro":"/api/v1/public/instrument-logo/2e2443e6-27e8-414c-867d-4f456934172e/logo/4ff45c4c-d15f-4b51-bc0e-49e85260908c/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.02","percent":"-0.002002","max":"0","min":"0"},"1w":{"value":"-0.11","percent":"-0.010913","max":"10.08","min":"9.99"},"1m":{"value":"0.09","percent":"0.009109","max":"10.1","min":"9.91"},"3m":{"value":"-0.76","percent":"-0.070829","max":"10.93","min":"9.84"},"6m":{"value":"-1.14","percent":"-0.10261","max":"15.7","min":"9.84"},"1y":null,"5y":null},"marketPrice":"9.97","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":689310000,"websiteUrl":"a.reinventtechnologypartners.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#A9D7F2","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":null,"ceo":"","employees":0},{"id":"483dc20a-e8d9-490c-afe6-2b59243938d8","urlSlug":"nasdaq-kdmn","instrumentType":"equity","symbol":"KDMN","kidsRecommended":false,"isVolatile":false,"name":"Kadmon Holdings Inc","description":"iShares Morningstar Small-Cap Growth ETF is an exchange-traded fund incorporate in the USA.  The ETF seeks investment results that correspond to the price and yield performance of the Morningstar Small Growth Index. The Index measures the performance of companies in the small-capitalization sector of the US equity market that are publicly traded on the NYSE, AMEX or Nasdaq. ","categories":["Healthcare","Manufacturing","Technology"],"logoIdentifier":"e8ba8fef-5f7c-46ef-bd63-1c4be19e62a4","logos":{"wide":"/api/v1/public/instrument-logo/483dc20a-e8d9-490c-afe6-2b59243938d8/logo/e8ba8fef-5f7c-46ef-bd63-1c4be19e62a4/1024/0","thumb":"/api/v1/public/instrument-logo/483dc20a-e8d9-490c-afe6-2b59243938d8/logo/e8ba8fef-5f7c-46ef-bd63-1c4be19e62a4/342/0","micro":"/api/v1/public/instrument-logo/483dc20a-e8d9-490c-afe6-2b59243938d8/logo/e8ba8fef-5f7c-46ef-bd63-1c4be19e62a4/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.005","percent":"0.00125","max":"0","min":"0"},"1w":{"value":"-0.095","percent":"-0.023171","max":"4.21","min":"4.0"},"1m":{"value":"0.28","percent":"0.075168","max":"4.21","min":"3.65"},"3m":{"value":"-0.265","percent":"-0.062061","max":"4.32","min":"3.565"},"6m":{"value":"-0.345","percent":"-0.07931","max":"5.51","min":"3.565"},"1y":{"value":"-0.695","percent":"-0.147872","max":"5.51","min":"3.19"},"5y":null},"marketPrice":"4.005","marketLastCheck":"2021-06-15T19:59:56Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-6.17","marketCap":688755325,"websiteUrl":"kadmon.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#62AED5","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.147872","ceo":"","employees":101},{"id":"f01ec256-1752-428a-8bbf-0fc42dfd4bdc","urlSlug":"asx-eos","instrumentType":"equity","symbol":"EOS","kidsRecommended":false,"isVolatile":false,"name":"Electro Optic Systems Hldg Ltd","description":"Electro Optic Systems Pty Ltd is an Australia-based technology company. The Company operates in three sectors: Defense, Space and Communications. The Company’s Defense Systems is specialized in technology for weapon systems optimization and integration, as well as intelligence, surveillance and reconnaissance (ISR) for land warfare. Its Space Systems are specialized in applying developed optical sensors to detect, track, classify and characterize objects in space. This information has both military and commercial applications, including managing space assets to avoid collisions with space debris, missile defense and space control. The Company’s Communication Systems provides global satellite communications services and systems. It specializes in optical, microwave and onthe-move radio and satellite products that help to deliver resilient and assured telecommunications anywhere in the world.","categories":["Technology"],"logoIdentifier":"5f91ff9d-ac3c-4a23-ba48-52668110fa50","logos":{"wide":"/api/v1/public/instrument-logo/f01ec256-1752-428a-8bbf-0fc42dfd4bdc/logo/5f91ff9d-ac3c-4a23-ba48-52668110fa50/1024/0","thumb":"/api/v1/public/instrument-logo/f01ec256-1752-428a-8bbf-0fc42dfd4bdc/logo/5f91ff9d-ac3c-4a23-ba48-52668110fa50/342/0","micro":"/api/v1/public/instrument-logo/f01ec256-1752-428a-8bbf-0fc42dfd4bdc/logo/5f91ff9d-ac3c-4a23-ba48-52668110fa50/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.09","percent":"0.020179","max":"0","min":"0"},"1w":{"value":"0.2","percent":"0.045977","max":"4.52","min":"4.35"},"1m":{"value":"0.7","percent":"0.181818","max":"4.52","min":"3.71"},"3m":{"value":"-1.09","percent":"-0.193262","max":"5.64","min":"3.71"},"6m":{"value":"-1.76","percent":"-0.278922","max":"6.41","min":"3.71"},"1y":{"value":"-1.04","percent":"-0.186047","max":"6.68","min":"3.71"},"5y":{"value":"2.75","percent":"1.527778","max":"10.53","min":"1.09"}},"marketPrice":"4.55","marketLastCheck":"2021-06-16T04:03:11Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":686660000,"websiteUrl":"http://www.eos-aus.com","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#5D779E","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.186047","ceo":"Ben Greene","employees":218},{"id":"8c22ba06-a6c3-41e0-b2e7-ddfeaaad02c5","urlSlug":"nasdaq-crnx","instrumentType":"equity","symbol":"CRNX","kidsRecommended":false,"isVolatile":false,"name":"Crinetics Pharmaceuticals Inc","description":"Crinetics Pharmaceuticals, Inc. is a clinical stage pharmaceutical company. The Company is focused on the discovery and development of drugs to treat specialty endocrine diseases and endocrine-related tumors. It develops a pipeline of oral nonpeptide chemical entities that target peptide G protein coupled receptors (GPCRs) for the treatment of endocrine diseases. The Company’s lead product candidate is CRN00808 developed for the treatment of acromegaly. It also develops two other product candidates CRN02481 for hyperinsulinemia, and CRN01941 for the treatment of neuroendocrine tumors. CRN02481 and CRN01941 are both oral nonpeptide somastatin receptors that are in the pre-clinical stages of development. The company also conducts research programs on developing nonpeptide products for the treatment of Cushing’s disease.","categories":["Healthcare","Technology"],"logoIdentifier":"f6eb39e3-d1ef-43dd-892f-1b81e6200af6","logos":{"wide":"/api/v1/public/instrument-logo/8c22ba06-a6c3-41e0-b2e7-ddfeaaad02c5/logo/f6eb39e3-d1ef-43dd-892f-1b81e6200af6/1024/0","thumb":"/api/v1/public/instrument-logo/8c22ba06-a6c3-41e0-b2e7-ddfeaaad02c5/logo/f6eb39e3-d1ef-43dd-892f-1b81e6200af6/342/0","micro":"/api/v1/public/instrument-logo/8c22ba06-a6c3-41e0-b2e7-ddfeaaad02c5/logo/f6eb39e3-d1ef-43dd-892f-1b81e6200af6/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.03","percent":"0.001646","max":"0","min":"0"},"1w":{"value":"0.06","percent":"0.003297","max":"18.94","min":"16.98"},"1m":{"value":"2.04","percent":"0.125771","max":"18.94","min":"16.39"},"3m":{"value":"1.72","percent":"0.10399","max":"18.94","min":"15.28"},"6m":{"value":"4.34","percent":"0.311782","max":"18.94","min":"13.09"},"1y":{"value":"1.39","percent":"0.082395","max":"23.23","min":"12.08"},"5y":null},"marketPrice":"18.26","marketLastCheck":"2021-06-15T19:59:50Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":686454954,"websiteUrl":"www.crinetics.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#79A4AB","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.082395","ceo":"R. Scott Struthers","employees":0},{"id":"398aca12-75fa-4e01-96ea-2131712ede6d","urlSlug":"nasdaq-icpt","instrumentType":"equity","symbol":"ICPT","kidsRecommended":false,"isVolatile":false,"name":"Intercept Pharmaceuticals Inc","description":"Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. The Company's product candidates have the potential to treat orphan and more prevalent diseases for which there are limited therapeutic solutions. The Company's product candidate, obeticholic acid (OCA), is a bile acid analog, a chemical substance that has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR). In addition to OCA, it is developing other bile acid analog compounds targeting FXR and a second dedicated bile acid receptor called TGR5, which is a target of interest for the treatment of type 2 diabetes and other gastrointestinal indications. The Company is also developing other products INT-767 for the treatment of fibrosis and INT-777 for the treatment of type 2 diabetes.","categories":["Healthcare","Manufacturing"],"logoIdentifier":"45450e5c-ad6c-4033-a9a1-54d3d67230be","logos":{"wide":"/api/v1/public/instrument-logo/398aca12-75fa-4e01-96ea-2131712ede6d/logo/45450e5c-ad6c-4033-a9a1-54d3d67230be/1024/0","thumb":"/api/v1/public/instrument-logo/398aca12-75fa-4e01-96ea-2131712ede6d/logo/45450e5c-ad6c-4033-a9a1-54d3d67230be/342/0","micro":"/api/v1/public/instrument-logo/398aca12-75fa-4e01-96ea-2131712ede6d/logo/45450e5c-ad6c-4033-a9a1-54d3d67230be/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.02","percent":"0.000968","max":"0","min":"0"},"1w":{"value":"-0.71","percent":"-0.033178","max":"21.56","min":"20.67"},"1m":{"value":"2.54","percent":"0.139945","max":"21.56","min":"15.46"},"3m":{"value":"-2.33","percent":"-0.101216","max":"24.88","min":"15.46"},"6m":{"value":"-9.73","percent":"-0.319855","max":"37.75","min":"15.46"},"1y":{"value":"-57.96","percent":"-0.736936","max":"81.88","min":"15.46"},"5y":{"value":"-120.89","percent":"-0.853864","max":"173.03","min":"15.46"}},"marketPrice":"20.69","marketLastCheck":"2021-06-15T19:59:58Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-3.08","marketCap":686123146,"websiteUrl":"www.interceptpharma.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#8FB5BA","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.736936","ceo":"","employees":583},{"id":"56eef8a7-3710-44dd-b459-3d08e94f6281","urlSlug":"asx-akp","instrumentType":"equity","symbol":"AKP","kidsRecommended":false,"isVolatile":false,"name":"Audio Pixels Holdings Ltd","description":"Audio Pixels Holdings Limited is engaged in investing in Audio Pixels Limited of Israel. The Company's subsidiary, Audio Pixels Limited, is engaged in the development of digital speakers. It operates through digital speakers segment. Its geographical segments include Australia and Israel. Its technologies employ techniques to generate sound waves directly from a digital audio stream using micro-electromechanical structures (MEMS). The MEMS-based Digital Sound Reconstruction platform enables the market for audio speakers to follow the evolution of the video display market from analog tube based monitors to the digital flat panel displays. It focuses on producing and selling a single type of chip that can be used either as a standalone speaker or cascaded in any multiples of up to 64 units of the same chip. The chip replaces conventional speaker driver(s), enclosure or acoustic chamber, as well as the electronic circuitry associated with converting the digital signal feed to analog.","categories":["Technology"],"logoIdentifier":"b4ac956a-3847-41b0-bace-ff775f9d2250","logos":{"wide":"/api/v1/public/instrument-logo/56eef8a7-3710-44dd-b459-3d08e94f6281/logo/b4ac956a-3847-41b0-bace-ff775f9d2250/1024/0","thumb":"/api/v1/public/instrument-logo/56eef8a7-3710-44dd-b459-3d08e94f6281/logo/b4ac956a-3847-41b0-bace-ff775f9d2250/342/0","micro":"/api/v1/public/instrument-logo/56eef8a7-3710-44dd-b459-3d08e94f6281/logo/b4ac956a-3847-41b0-bace-ff775f9d2250/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.85","percent":"0.036876","max":"23.9","min":"22.87"},"1m":{"value":"3.9","percent":"0.195","max":"25.0","min":"18.99"},"3m":{"value":"-3.01","percent":"-0.111854","max":"29.4","min":"18.99"},"6m":{"value":"0.03","percent":"0.001257","max":"29.5","min":"18.99"},"1y":{"value":"4.05","percent":"0.20403","max":"31.07","min":"17.51"},"5y":{"value":"4.47","percent":"0.230057","max":"33.34","min":"9.0"}},"marketPrice":"23.9","marketLastCheck":"2021-06-16T04:03:06Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":685898000,"websiteUrl":"http://www.audiopixels.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":null,"pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.20403","ceo":null,"employees":15},{"id":"d35bf5e0-d7db-46d0-9316-bbe98ac4847d","urlSlug":"nasdaq-ccrn","instrumentType":"equity","symbol":"CCRN","kidsRecommended":false,"isVolatile":false,"name":"Cross Country Healthcares, Inc.","description":"Cross Country Healthcare, Inc. is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing. The Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners and physician assistants under its Medical Doctor Associates brand. The Other Human Capital Management Services is engaged in providing retained and contingent search services for physicians, healthcare executives, nurses, advanced practice and allied health professionals. It provides multi-specialty locum tenens services, as well as other human capital management services focused on healthcare.","categories":["Manufacturing","Services"],"logoIdentifier":"c7eafa77-8c50-4de3-a546-17fd70e98705","logos":{"wide":"/api/v1/public/instrument-logo/d35bf5e0-d7db-46d0-9316-bbe98ac4847d/logo/c7eafa77-8c50-4de3-a546-17fd70e98705/1024/0","thumb":"/api/v1/public/instrument-logo/d35bf5e0-d7db-46d0-9316-bbe98ac4847d/logo/c7eafa77-8c50-4de3-a546-17fd70e98705/342/0","micro":"/api/v1/public/instrument-logo/d35bf5e0-d7db-46d0-9316-bbe98ac4847d/logo/c7eafa77-8c50-4de3-a546-17fd70e98705/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.07","percent":"0.003861","max":"0","min":"0"},"1w":{"value":"1.2","percent":"0.070588","max":"18.13","min":"17.0"},"1m":{"value":"2.25","percent":"0.141066","max":"18.13","min":"15.18"},"3m":{"value":"5.52","percent":"0.435331","max":"18.13","min":"11.87"},"6m":{"value":"8.53","percent":"0.88211","max":"18.13","min":"8.72"},"1y":{"value":"12.03","percent":"1.949757","max":"18.13","min":"5.59"},"5y":{"value":"4.22","percent":"0.30186","max":"18.13","min":"4.75"}},"marketPrice":"18.2","marketLastCheck":"2021-06-15T19:59:53Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"77.22","marketCap":685570868,"websiteUrl":"www.crosscountryhealthcare.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#9E7891","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"1.949757","ceo":"Kevin Clark","employees":1700},{"id":"4b7908a6-b37c-4faa-89b9-4380a3ebdbb3","urlSlug":"nasdaq-veru","instrumentType":"equity","symbol":"VERU","kidsRecommended":false,"isVolatile":false,"name":"Veru Inc","description":"Veru Inc. is an oncology and urology biopharmaceutical company with a focus on developing medicines for the management of prostate cancer. The Company operates in two segments: Commercial and Research, and Development. The Commercial segment consists of FC2. The Research and Development segment consists of multiple drug products under clinical development for oncology and urology. The Company's prostate cancer pipeline includes VERU-111, VERU-100 and Zuclomiphene Citrate. VERU-111 is an oral chemical entity that targets, crosslinks, and disrupts alpha and beta tubulin subunits of microtubules. VERU-100 is a peptide formulation designed to address the limitations of commercially available androgen deprivation therapies (ADT) for advanced prostate cancer. The Company's commercial products include FC2 Female Condom/FC2 Internal Condom (FC2), a product for the protection against unintended pregnancy and sexually transmitted infections.","categories":["Healthcare","Manufacturing"],"logoIdentifier":"6b84c403-0c13-4661-8726-81942c1dcab9","logos":{"wide":"/api/v1/public/instrument-logo/4b7908a6-b37c-4faa-89b9-4380a3ebdbb3/logo/6b84c403-0c13-4661-8726-81942c1dcab9/1024/0","thumb":"/api/v1/public/instrument-logo/4b7908a6-b37c-4faa-89b9-4380a3ebdbb3/logo/6b84c403-0c13-4661-8726-81942c1dcab9/342/0","micro":"/api/v1/public/instrument-logo/4b7908a6-b37c-4faa-89b9-4380a3ebdbb3/logo/6b84c403-0c13-4661-8726-81942c1dcab9/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.01","percent":"-0.001161","max":"0","min":"0"},"1w":{"value":"-0.42","percent":"-0.046563","max":"9.02","min":"8.61"},"1m":{"value":"1.04","percent":"0.137566","max":"9.14","min":"7.77"},"3m":{"value":"-6.23","percent":"-0.420094","max":"14.91","min":"7.24"},"6m":{"value":"-1.39","percent":"-0.139139","max":"20.78","min":"7.24"},"1y":{"value":"5.2","percent":"1.529412","max":"20.78","min":"2.36"},"5y":{"value":"7.2","percent":"5.142857","max":"20.78","min":"0.82"}},"marketPrice":"8.6","marketLastCheck":"2021-06-15T19:59:45Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-1303.03","marketCap":685278564,"websiteUrl":"verupharma.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#8F9C81","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"1.529412","ceo":"Mitchell Steiner","employees":0},{"id":"282839bd-0fbb-465a-9cb8-5ea0eea9419d","urlSlug":"nasdaq-lxrx","instrumentType":"equity","symbol":"LXRX","kidsRecommended":false,"isVolatile":false,"name":"Lexicon Pharmaceuticals Inc","description":"Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of treatments for human disease. The Company's drug programs include Sotagliflozin and LX9211. The Company also has a number of additional compounds into various stages of clinical and preclinical development. The Company’s LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The Company intends to initiate a Phase IIa clinical trial evaluating the safety and tolerability of LX9211 and its effects on diabetic peripheral neuropathic (DPN) pain. Its Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of type I diabetes and type II diabetes, heart failure and chronic kidney disease. ","categories":["Healthcare","Manufacturing","Technology"],"logoIdentifier":"61ef7e4b-32e6-4c3c-8b88-7cb81c6d17c2","logos":{"wide":"/api/v1/public/instrument-logo/282839bd-0fbb-465a-9cb8-5ea0eea9419d/logo/61ef7e4b-32e6-4c3c-8b88-7cb81c6d17c2/1024/0","thumb":"/api/v1/public/instrument-logo/282839bd-0fbb-465a-9cb8-5ea0eea9419d/logo/61ef7e4b-32e6-4c3c-8b88-7cb81c6d17c2/342/0","micro":"/api/v1/public/instrument-logo/282839bd-0fbb-465a-9cb8-5ea0eea9419d/logo/61ef7e4b-32e6-4c3c-8b88-7cb81c6d17c2/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.2","percent":"-0.040486","max":"4.94","min":"4.74"},"1m":{"value":"0.41","percent":"0.094688","max":"4.94","min":"4.12"},"3m":{"value":"-1.92","percent":"-0.288288","max":"6.69","min":"4.12"},"6m":{"value":"1.71","percent":"0.564356","max":"9.09","min":"3.03"},"1y":{"value":"2.88","percent":"1.548387","max":"9.09","min":"1.05"},"5y":{"value":"-9.09","percent":"-0.657267","max":"19.3","min":"1.05"}},"marketPrice":"4.74","marketLastCheck":"2021-06-15T19:59:54Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-44.05","marketCap":684398167,"websiteUrl":"www.lexpharma.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#71BB7D","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"1.548387","ceo":"","employees":225},{"id":"935cdb78-5e99-4db7-b0e6-d16eb55f3545","urlSlug":"nyse-kop","instrumentType":"equity","symbol":"KOP","kidsRecommended":false,"isVolatile":false,"name":"Koppers Holdings Inc","description":"Koppers Holdings Inc. is a global integrated provider of treated wood products, wood treatment chemicals and carbon compounds. The Company operates through three segments: Railroad and Utility Products and Services (RUPS), Carbon Materials and Chemicals (CMC) and Performance Chemicals (PC). The RUPS business sells treated and untreated wood products, rail joint bars and services primarily to the railroad markets. The primary products supplied by PC business are copper-based wood preservatives, including micronized copper quaternary and micronized copper azole (MicroPro), micronized pigments (MicroShades) and chromated copper arsenate. Through CMC business, the Company processes coal tar into a range of products, including carbon pitch, creosote and carbon black feedstock. Its products and services are used in a range of markets, including the railroad, specialty chemical, utility, residential lumber, agriculture, aluminum, steel, rubber and construction industries.","categories":["Manufacturing"],"logoIdentifier":"d6925cb7-6e09-4d78-a09e-1c88562c9be9","logos":{"wide":"/api/v1/public/instrument-logo/935cdb78-5e99-4db7-b0e6-d16eb55f3545/logo/d6925cb7-6e09-4d78-a09e-1c88562c9be9/1024/0","thumb":"/api/v1/public/instrument-logo/935cdb78-5e99-4db7-b0e6-d16eb55f3545/logo/d6925cb7-6e09-4d78-a09e-1c88562c9be9/342/0","micro":"/api/v1/public/instrument-logo/935cdb78-5e99-4db7-b0e6-d16eb55f3545/logo/d6925cb7-6e09-4d78-a09e-1c88562c9be9/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-1.36","percent":"-0.0405","max":"33.58","min":"32.22"},"1m":{"value":"-2.94","percent":"-0.083618","max":"35.25","min":"32.22"},"3m":{"value":"-4.0","percent":"-0.110436","max":"38.22","min":"32.22"},"6m":{"value":"4.16","percent":"0.148254","max":"38.22","min":"27.28"},"1y":{"value":"14.28","percent":"0.795987","max":"38.22","min":"17.25"},"5y":{"value":"2.88","percent":"0.09816","max":"51.45","min":"8.38"}},"marketPrice":"32.22","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"4.64","marketCap":684380541,"websiteUrl":"www.koppers.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#35895C","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.795987","ceo":"","employees":2100},{"id":"0420eb05-b492-4c04-89ad-6b11bf1625dd","urlSlug":"nasdaq-cgen","instrumentType":"equity","symbol":"CGEN","kidsRecommended":false,"isVolatile":false,"name":"Compugen Ltd","description":"Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immunotherapy. The Company's lead product candidate, COM701, a first-in-class anti-PVRIG antibody, for the treatment of solid tumors, is undergoing a Phase 1 clinical study. In addition, COM902, Compugen's antibody targeting TIGIT, is expected to enter the clinic in early 2020. The Company's therapeutic pipeline also includes early-stage immuno-oncology programs focused largely on myeloid targets. Compugen's business model is to selectively enter into collaborations for its novel targets and related drug product candidates at various stages of research and development. The Company is headquartered in Israel, with offices in South San Francisco, CA.","categories":["Healthcare","Manufacturing","Technology"],"logoIdentifier":"147f5b7c-3f39-4b2b-aade-42bb81bfab09","logos":{"wide":"/api/v1/public/instrument-logo/0420eb05-b492-4c04-89ad-6b11bf1625dd/logo/147f5b7c-3f39-4b2b-aade-42bb81bfab09/1024/0","thumb":"/api/v1/public/instrument-logo/0420eb05-b492-4c04-89ad-6b11bf1625dd/logo/147f5b7c-3f39-4b2b-aade-42bb81bfab09/342/0","micro":"/api/v1/public/instrument-logo/0420eb05-b492-4c04-89ad-6b11bf1625dd/logo/147f5b7c-3f39-4b2b-aade-42bb81bfab09/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.001227","max":"0","min":"0"},"1w":{"value":"0.34","percent":"0.043478","max":"8.51","min":"7.82"},"1m":{"value":"0.16","percent":"0.02","max":"8.51","min":"7.23"},"3m":{"value":"-0.95","percent":"-0.104281","max":"9.22","min":"6.87"},"6m":{"value":"-3.91","percent":"-0.323944","max":"14.19","min":"6.87"},"1y":{"value":"-6.66","percent":"-0.449393","max":"19.45","min":"6.87"},"5y":{"value":"1.56","percent":"0.236364","max":"19.45","min":"2.17"}},"marketPrice":"8.16","marketLastCheck":"2021-06-15T19:59:40Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":682794985,"websiteUrl":"www.cgen.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#749BB3","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.449393","ceo":"","employees":0},{"id":"3594cd1e-9891-4c85-89d6-f79bef5d222a","urlSlug":"asx-cmm","instrumentType":"equity","symbol":"CMM","kidsRecommended":false,"isVolatile":false,"name":"Capricorn Metals Ltd","description":"Capricorn Metals Limited is a gold explorer and developer, based in Perth, Western Australia. The Company’s exploration and real estate assets held in Madagascar are to be divested, with all funds directed towards gold exploration at Karlawinda. The Karlawinda Project includes is located approximately 65kilometres south of Newman in the Pilbara mining province in Western Australia. The Karlawinda Project includes the Bibra gold deposit and numerous outstanding exploration targets, including the advanced Francopan gold prospect, within an under-explored 290 square kilometer tenement package. The Bibra deposit has a JORC 2012 inferred resource of 18 million tons at the rate 1.1g/t Au for 650,800oz Au contained within an optimized pit design at A$1600/ounce gold price. On February 2016, the Company completed the acquisition of the Karlawinda Gold Project in Western Australia.","categories":["Mining, oil and gas"],"logoIdentifier":"38f81dec-8ccb-483c-bdde-2c64da26e52a","logos":{"wide":"/api/v1/public/instrument-logo/3594cd1e-9891-4c85-89d6-f79bef5d222a/logo/38f81dec-8ccb-483c-bdde-2c64da26e52a/1024/0","thumb":"/api/v1/public/instrument-logo/3594cd1e-9891-4c85-89d6-f79bef5d222a/logo/38f81dec-8ccb-483c-bdde-2c64da26e52a/342/0","micro":"/api/v1/public/instrument-logo/3594cd1e-9891-4c85-89d6-f79bef5d222a/logo/38f81dec-8ccb-483c-bdde-2c64da26e52a/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.03","percent":"-0.015152","max":"0","min":"0"},"1w":{"value":"-0.02","percent":"-0.010152","max":"2.01","min":"1.97"},"1m":{"value":"0.17","percent":"0.095506","max":"2.06","min":"1.775"},"3m":{"value":"0.375","percent":"0.238095","max":"2.06","min":"1.41"},"6m":{"value":"0.285","percent":"0.171171","max":"2.06","min":"1.41"},"1y":{"value":"0.36","percent":"0.226415","max":"2.26","min":"1.41"},"5y":{"value":"1.2523325","percent":"1.795028","max":"2.26","min":"0.240575"}},"marketPrice":"1.95","marketLastCheck":"2021-06-16T04:03:08Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":682538000,"websiteUrl":"http://capmetals.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#695C3B","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.226415","ceo":"Kim Massey","employees":0},{"id":"ce41ea55-392a-49f9-91f1-e298a4ddc473","urlSlug":"nasdaq-allt","instrumentType":"equity","symbol":"ALLT","kidsRecommended":false,"isVolatile":false,"name":"Allot Ltd","description":"Allot Communications Ltd. (Allot) is a global provider of security and monetization solutions that enable mobile, fixed and enterprise service providers to protect and personalize the digital experience. The Company has a global and diverse customer base composed of mobile and fixed broadband service providers, cable operators, private networks, data centers, governments and enterprises, such as financial and educational institutions. Its integrated solutions include analytics, traffic management, video caching and optimization, policy control and charging, service enablement and security solutions. The Allot Service Gateway platforms (including Allot Service Gateway Tera, and Allot Service Gateway 9500), as well as Allot NetEnforcer platforms are based on technology, designed for in-line deployment in a range of networks. Allot service Gateway platforms are designed for deployment both on traditional and virtualized network access infrastructure.","categories":["Services","Technology"],"logoIdentifier":"f5566cee-fda7-46f4-9b3a-5f3f3871edbd","logos":{"wide":"/api/v1/public/instrument-logo/ce41ea55-392a-49f9-91f1-e298a4ddc473/logo/f5566cee-fda7-46f4-9b3a-5f3f3871edbd/1024/0","thumb":"/api/v1/public/instrument-logo/ce41ea55-392a-49f9-91f1-e298a4ddc473/logo/f5566cee-fda7-46f4-9b3a-5f3f3871edbd/342/0","micro":"/api/v1/public/instrument-logo/ce41ea55-392a-49f9-91f1-e298a4ddc473/logo/f5566cee-fda7-46f4-9b3a-5f3f3871edbd/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.025","percent":"-0.001295","max":"0","min":"0"},"1w":{"value":"0.325","percent":"0.017141","max":"20.47","min":"18.96"},"1m":{"value":"2.205","percent":"0.129098","max":"20.47","min":"16.775"},"3m":{"value":"3.205","percent":"0.199316","max":"20.47","min":"14.62"},"6m":{"value":"8.635","percent":"0.810798","max":"20.47","min":"10.38"},"1y":{"value":"8.825","percent":"0.84369","max":"20.47","min":"8.68"},"5y":{"value":"14.075","percent":"2.701536","max":"20.47","min":"4.55"}},"marketPrice":"19.285","marketLastCheck":"2021-06-15T19:59:46Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-58.35","marketCap":682354174,"websiteUrl":"www.allot.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#B38364","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.84369","ceo":"Erez Antebi","employees":700},{"id":"412a4f09-5232-49ef-a702-ac83cf0aa02b","urlSlug":"asx-djw","instrumentType":"equity","symbol":"DJW","kidsRecommended":false,"isVolatile":false,"name":"Djerriwarrh Investments Limited","description":"Djerriwarrh Investments Limited is a closed end investment company. The Company is engaged in investing in Australian equities with a focus on stocks where there is an active options market. The Company's investment objective is to provide attractive total returns including capital growth over the medium to long term, and to pay an enhanced level of dividends. The Company invests in a range of sectors, including Energy, materials, industrials, consumer staples, banks, other financials (including property trusts), telecommunications, healthcare, other sectors, such as consumer discretionary, information technology and utilities, and cash. The Company uses exchange-traded options to enhance income return to investors. It holds a portfolio of approximately 50 companies.","categories":["Strategic funds"],"logoIdentifier":"77d421ea-aa79-4e47-abfc-d1a385d5dade","logos":{"wide":"/api/v1/public/instrument-logo/412a4f09-5232-49ef-a702-ac83cf0aa02b/logo/77d421ea-aa79-4e47-abfc-d1a385d5dade/1024/0","thumb":"/api/v1/public/instrument-logo/412a4f09-5232-49ef-a702-ac83cf0aa02b/logo/77d421ea-aa79-4e47-abfc-d1a385d5dade/342/0","micro":"/api/v1/public/instrument-logo/412a4f09-5232-49ef-a702-ac83cf0aa02b/logo/77d421ea-aa79-4e47-abfc-d1a385d5dade/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.07","percent":"0.023649","max":"3.04","min":"2.96"},"1m":{"value":"0.11","percent":"0.037671","max":"3.04","min":"2.89"},"3m":{"value":"0.14","percent":"0.048443","max":"3.04","min":"2.74"},"6m":{"value":"-0.04","percent":"-0.013029","max":"3.15","min":"2.74"},"1y":{"value":"0.41","percent":"0.156489","max":"3.15","min":"2.42"},"5y":{"value":"-1.02","percent":"-0.251852","max":"4.18","min":"2.06"}},"marketPrice":"3.03","marketLastCheck":"2021-06-16T04:03:10Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"40.29","marketCap":682334000,"websiteUrl":"http://www.djerri.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#A7B76F","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0347","annualisedReturnPercent":"0.191189","ceo":"R. Mark Freeman","employees":0},{"id":"ddcb8065-d9f4-464c-8433-fb0566c1aea6","urlSlug":"nasdaq-tcrr","instrumentType":"equity","symbol":"TCRR","kidsRecommended":false,"isVolatile":false,"name":"Tcr2 Therapeutics Inc","description":"TCR2 Therapeutics, Inc. is an immunotherapy company, which is developing novel T cell therapies for patients suffering from cancer. The Company’s T cell receptor (TCR) Fusion Construct T cells (TRuC-T cells) specifically recognize and kill cancer cells by harnessing the entire T cell receptor (TCR) signaling complex. The Company has demonstrated anti-tumor activity of TRuC-T cells in preclinical models across various tumor targets. The Company has also developed combinations of TRuC variants with elements designed to sustain the immunotherapeutic response and counteract the immunosuppressive tumor microenvironment. Its platform is highlighted with multiple programs of product candidate, which include TC-210, TC-220, TC-410, TC-110 and TC-310.","categories":["Healthcare","Manufacturing"],"logoIdentifier":"69bfda87-16b1-4b9b-8cc2-dec3fa999c54","logos":{"wide":"/api/v1/public/instrument-logo/ddcb8065-d9f4-464c-8433-fb0566c1aea6/logo/69bfda87-16b1-4b9b-8cc2-dec3fa999c54/1024/0","thumb":"/api/v1/public/instrument-logo/ddcb8065-d9f4-464c-8433-fb0566c1aea6/logo/69bfda87-16b1-4b9b-8cc2-dec3fa999c54/342/0","micro":"/api/v1/public/instrument-logo/ddcb8065-d9f4-464c-8433-fb0566c1aea6/logo/69bfda87-16b1-4b9b-8cc2-dec3fa999c54/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.01","percent":"-0.00056","max":"0","min":"0"},"1w":{"value":"-0.53","percent":"-0.028836","max":"18.38","min":"17.53"},"1m":{"value":"-1.63","percent":"-0.083676","max":"20.1","min":"17.53"},"3m":{"value":"-8.34","percent":"-0.318442","max":"26.19","min":"17.53"},"6m":{"value":"-9.65","percent":"-0.350909","max":"34.07","min":"17.53"},"1y":{"value":"1.74","percent":"0.108007","max":"34.07","min":"13.1"},"5y":null},"marketPrice":"17.85","marketLastCheck":"2021-06-15T19:59:36Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":681199768,"websiteUrl":"www.tcr2.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#8EA2BE","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.108007","ceo":"Garry Menzel","employees":2000},{"id":"d00ba102-d8ea-4a63-9aec-bcfbe303eb81","urlSlug":"nasdaq-posh","instrumentType":"equity","symbol":"POSH","kidsRecommended":false,"isVolatile":false,"name":"Poshmark Inc","description":"Poshmark is a leading social marketplace for new and secondhand style for women, men, kids, home, and more. By combining the human connection of physical shopping with the scale, ease, and selection benefits of ecommerce, Poshmark makes buying and selling simple, social, and fun. Its community of more than 70 million registered users across the U.S. and Canada is driving the future of commerce while promoting more sustainable consumption.","categories":["Retail"],"logoIdentifier":"f8b83eaf-7920-4c10-8fab-49464f7335c4","logos":{"wide":"/api/v1/public/instrument-logo/d00ba102-d8ea-4a63-9aec-bcfbe303eb81/logo/f8b83eaf-7920-4c10-8fab-49464f7335c4/1024/0","thumb":"/api/v1/public/instrument-logo/d00ba102-d8ea-4a63-9aec-bcfbe303eb81/logo/f8b83eaf-7920-4c10-8fab-49464f7335c4/342/0","micro":"/api/v1/public/instrument-logo/d00ba102-d8ea-4a63-9aec-bcfbe303eb81/logo/f8b83eaf-7920-4c10-8fab-49464f7335c4/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.14","percent":"0.003178","max":"0","min":"0"},"1w":{"value":"-2.16","percent":"-0.046602","max":"46.6","min":"44.05"},"1m":{"value":"7.61","percent":"0.208037","max":"51.19","min":"33.99"},"3m":{"value":"-2.18","percent":"-0.047013","max":"51.19","min":"33.99"},"6m":null,"1y":null,"5y":null},"marketPrice":"44.19","marketLastCheck":"2021-06-15T19:59:38Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"198.96","marketCap":681161010,"websiteUrl":"poshmark.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#C4818D","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":null,"ceo":"","employees":300},{"id":"10070500-df87-46cc-b78b-8fa9ef774d37","urlSlug":"nasdaq-osur","instrumentType":"equity","symbol":"OSUR","kidsRecommended":false,"isVolatile":false,"name":"Orasure Technologies Inc.","description":"OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.","categories":["Healthcare","Manufacturing"],"logoIdentifier":"43eefa64-5e31-4d30-b648-db8f3fc213bc","logos":{"wide":"/api/v1/public/instrument-logo/10070500-df87-46cc-b78b-8fa9ef774d37/logo/43eefa64-5e31-4d30-b648-db8f3fc213bc/1024/0","thumb":"/api/v1/public/instrument-logo/10070500-df87-46cc-b78b-8fa9ef774d37/logo/43eefa64-5e31-4d30-b648-db8f3fc213bc/342/0","micro":"/api/v1/public/instrument-logo/10070500-df87-46cc-b78b-8fa9ef774d37/logo/43eefa64-5e31-4d30-b648-db8f3fc213bc/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.005","percent":"0.000529","max":"0","min":"0"},"1w":{"value":"-0.255","percent":"-0.026262","max":"9.71","min":"9.45"},"1m":{"value":"-0.055","percent":"-0.005783","max":"10.05","min":"9.29"},"3m":{"value":"-1.805","percent":"-0.160302","max":"11.68","min":"9.02"},"6m":{"value":"-1.945","percent":"-0.170614","max":"15.42","min":"9.02"},"1y":{"value":"-1.265","percent":"-0.118004","max":"19.58","min":"9.02"},"5y":{"value":"2.505","percent":"0.360432","max":"22.81","min":"5.57"}},"marketPrice":"9.455","marketLastCheck":"2021-06-15T19:59:53Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-173.81","marketCap":680382254,"websiteUrl":"www.orasure.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#6C8EB6","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.118004","ceo":"Douglas Michels","employees":472},{"id":"60cde768-7bb0-40e6-a2b7-20b4b151200d","urlSlug":"nyse-bfk","instrumentType":"equity","symbol":"BFK","kidsRecommended":false,"isVolatile":false,"name":"BlackRock Municipal Income Trust","description":"BlackRock Municipal Income Trust (the Trust) is a diversified closed-end management investment company. The Trust's investment objective is to provide current income exempt from regular federal income tax. The Trust seeks to achieve its investment objective by investing primarily in municipal bonds exempt from federal income taxes. It investment in sectors, including transport, health, utility, state tax-backed, corporate muni, education, tobacco, other industries, local tax-backed, prerefund/escrow, school districts, housing, and cash and derivatives. It invests in California, Illinois, New York, Texas, New Jersey, Alabama, South Carolina, Ohio, Washington and District of Columbia. It invests, under normal market conditions, at least 80% of its assets in municipal bonds that are investment grade quality at the time of investment. It may invest directly in such securities or through the use of derivatives. The Trust's investment manager and adviser is BlackRock Advisors, LLC.","categories":["Banking and finance"],"logoIdentifier":"36d6fc12-a4e5-48b4-98fe-64c5e4b6802e","logos":{"wide":"/api/v1/public/instrument-logo/60cde768-7bb0-40e6-a2b7-20b4b151200d/logo/36d6fc12-a4e5-48b4-98fe-64c5e4b6802e/1024/0","thumb":"/api/v1/public/instrument-logo/60cde768-7bb0-40e6-a2b7-20b4b151200d/logo/36d6fc12-a4e5-48b4-98fe-64c5e4b6802e/342/0","micro":"/api/v1/public/instrument-logo/60cde768-7bb0-40e6-a2b7-20b4b151200d/logo/36d6fc12-a4e5-48b4-98fe-64c5e4b6802e/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.02","percent":"-0.001318","max":"0","min":"0"},"1w":{"value":"-0.04","percent":"-0.002633","max":"15.3","min":"15.15"},"1m":{"value":"0.17","percent":"0.011348","max":"15.3","min":"14.99"},"3m":{"value":"0.67","percent":"0.046271","max":"15.3","min":"14.39"},"6m":{"value":"0.31","percent":"0.020889","max":"15.47","min":"14.39"},"1y":{"value":"1.92","percent":"0.145125","max":"15.47","min":"13.17"},"5y":{"value":"-0.53","percent":"-0.033801","max":"15.99","min":"10.15"}},"marketPrice":"15.15","marketLastCheck":"2021-06-15T19:59:57Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":680091428,"websiteUrl":"www.blackrock.com/investing/products/240218/blackrock-municipal-income-trust-usd-fund","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#6E6E6E","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.041043162764000725","annualisedReturnPercent":"0.18616816276400072","ceo":"John Perlowski","employees":0},{"id":"949c7318-4d33-46a2-8bba-f25cd94b3481","urlSlug":"nyse-bbdc","instrumentType":"equity","symbol":"BBDC","kidsRecommended":false,"isVolatile":false,"name":"Barings BDC Inc","description":"Barings BDC, Inc. is an externally managed business development company (BDC). The Company primarily invests in senior secured private debt investments in performing middle-market businesses that operate across a range of industries. The Company is managed by Barings, LLC, a global asset manager.","categories":["Banking and finance"],"logoIdentifier":"5daab2f9-3377-464a-b1fb-979237555d93","logos":{"wide":"/api/v1/public/instrument-logo/949c7318-4d33-46a2-8bba-f25cd94b3481/logo/5daab2f9-3377-464a-b1fb-979237555d93/1024/0","thumb":"/api/v1/public/instrument-logo/949c7318-4d33-46a2-8bba-f25cd94b3481/logo/5daab2f9-3377-464a-b1fb-979237555d93/342/0","micro":"/api/v1/public/instrument-logo/949c7318-4d33-46a2-8bba-f25cd94b3481/logo/5daab2f9-3377-464a-b1fb-979237555d93/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.09","percent":"-0.008571","max":"10.59","min":"10.41"},"1m":{"value":"-0.08","percent":"-0.007626","max":"10.76","min":"10.41"},"3m":{"value":"0.36","percent":"0.035821","max":"10.76","min":"9.85"},"6m":{"value":"1.31","percent":"0.143956","max":"10.76","min":"8.83"},"1y":{"value":"2.77","percent":"0.362565","max":"10.76","min":"7.34"},"5y":{"value":"-8.19","percent":"-0.440323","max":"20.55","min":"5.34"}},"marketPrice":"10.41","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":679940445,"websiteUrl":"baringsbdc.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#73869F","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.06678909905129193","annualisedReturnPercent":"0.4293540990512919","ceo":"Eric Lloyd","employees":0},{"id":"e18ccc6a-69ae-4eaf-a253-cbceb20d5f67","urlSlug":"nyse-apgb","instrumentType":"equity","symbol":"APGB","kidsRecommended":false,"isVolatile":false,"name":"Apollo Strategic Growth Capital II","description":"Apollo Strategic Growth Capital II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not commenced any business operations and has not generated any revenue.","categories":[],"logoIdentifier":"2682d61f-59eb-43b7-8458-66dd7755c688","logos":{"wide":"/api/v1/public/instrument-logo/e18ccc6a-69ae-4eaf-a253-cbceb20d5f67/logo/2682d61f-59eb-43b7-8458-66dd7755c688/1024/0","thumb":"/api/v1/public/instrument-logo/e18ccc6a-69ae-4eaf-a253-cbceb20d5f67/logo/2682d61f-59eb-43b7-8458-66dd7755c688/342/0","micro":"/api/v1/public/instrument-logo/e18ccc6a-69ae-4eaf-a253-cbceb20d5f67/logo/2682d61f-59eb-43b7-8458-66dd7755c688/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.03","percent":"0.003055","max":"9.85","min":"9.82"},"1m":{"value":"0.0325","percent":"0.00331","max":"9.86","min":"9.76"},"3m":null,"6m":null,"1y":null,"5y":null},"marketPrice":"9.85","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":679650000,"websiteUrl":"","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#78AE9C","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":null,"ceo":"","employees":0},{"id":"0699a436-3af8-4efe-ae92-f250a1423fb3","urlSlug":"nyse-splp","instrumentType":"equity","symbol":"SPLP","kidsRecommended":false,"isVolatile":false,"name":"Steel Partners Holdings LP","description":"Steel Partners Holdings L.P. (SPLP), is a diversified holding company that engages in multiple businesses through consolidated subsidiaries, associated companies and other interests. The Company's segments are Diversified Industrial, Energy, Financial Services, and Corporate and Other. The Company owns and operates businesses, and has investments in companies, in various industries, including diversified industrial products, energy, defense, supply chain management and logistics, banking and youth sports.","categories":["Manufacturing","Technology"],"logoIdentifier":"98174799-276e-4010-abfa-585cac2ca938","logos":{"wide":"/api/v1/public/instrument-logo/0699a436-3af8-4efe-ae92-f250a1423fb3/logo/98174799-276e-4010-abfa-585cac2ca938/1024/0","thumb":"/api/v1/public/instrument-logo/0699a436-3af8-4efe-ae92-f250a1423fb3/logo/98174799-276e-4010-abfa-585cac2ca938/342/0","micro":"/api/v1/public/instrument-logo/0699a436-3af8-4efe-ae92-f250a1423fb3/logo/98174799-276e-4010-abfa-585cac2ca938/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.02","percent":"-0.000655","max":"0","min":"0"},"1w":{"value":"2.83","percent":"0.102277","max":"30.52","min":"27.67"},"1m":{"value":"8.83","percent":"0.407476","max":"30.52","min":"20.7"},"3m":{"value":"16.5","percent":"1.178571","max":"30.52","min":"13.71"},"6m":{"value":"21.65","percent":"2.446328","max":"30.52","min":"8.775"},"1y":{"value":"24.25","percent":"3.88","max":"30.52","min":"4.77"},"5y":{"value":"16.31","percent":"1.149401","max":"30.52","min":"4.45"}},"marketPrice":"30.5","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":679006732,"websiteUrl":"www.steelpartners.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#989BB7","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"3.88","ceo":"","employees":5000},{"id":"059b23e2-1caf-4ca5-a0d2-b9104802b8fe","urlSlug":"nyse-acre","instrumentType":"equity","symbol":"ACRE","kidsRecommended":false,"isVolatile":false,"name":"Ares Commercial Real Estate Corp","description":"Ares Commercial Real Estate Corporation is a specialty finance company. The Company is primarily engaged in originating and investing in commercial real estate (CRE) loans and related investments. The Company operates through principal lending segment. Its target investments include senior mortgage loans, subordinated debt, preferred equity, mezzanine loans and other CRE investment opportunities, including commercial mortgage-backed securities. These investments are generally held for investment and are secured, directly or indirectly, by office, multifamily, retail, industrial, lodging, senior-living, self-storage and other commercial real estate properties, or by ownership interests therein. Through the Company's manager, Ares Commercial Real Estate Management LLC, it has investment professionals located across the United States and Europe who directly source loan opportunities for the Company with owners, operators and sponsors of CRE properties.","categories":["Banking and finance"],"logoIdentifier":"75312e7b-1fac-4c45-86df-0ed30653b747","logos":{"wide":"/api/v1/public/instrument-logo/059b23e2-1caf-4ca5-a0d2-b9104802b8fe/logo/75312e7b-1fac-4c45-86df-0ed30653b747/1024/0","thumb":"/api/v1/public/instrument-logo/059b23e2-1caf-4ca5-a0d2-b9104802b8fe/logo/75312e7b-1fac-4c45-86df-0ed30653b747/342/0","micro":"/api/v1/public/instrument-logo/059b23e2-1caf-4ca5-a0d2-b9104802b8fe/logo/75312e7b-1fac-4c45-86df-0ed30653b747/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.000597","max":"0","min":"0"},"1w":{"value":"-0.04","percent":"-0.002381","max":"16.92","min":"16.59"},"1m":{"value":"1.92","percent":"0.12938","max":"16.92","min":"14.88"},"3m":{"value":"2.31","percent":"0.159862","max":"16.92","min":"13.72"},"6m":{"value":"3.88","percent":"0.301242","max":"16.92","min":"11.32"},"1y":{"value":"7.49","percent":"0.807983","max":"16.92","min":"8.02"},"5y":{"value":"4.56","percent":"0.37377","max":"17.68","min":"4.19"}},"marketPrice":"16.76","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"10.34","marketCap":678393777,"websiteUrl":"www.arescre.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#858E93","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.07499297757402067","annualisedReturnPercent":"0.8829759775740207","ceo":"Bryan Donohoe","employees":0},{"id":"55c961b6-355a-44ab-bf15-132c6a5c5a09","urlSlug":"asx-nwh","instrumentType":"equity","symbol":"NWH","kidsRecommended":false,"isVolatile":false,"name":"NRW Holdings Limited","description":"NRW Holdings Limited is a holding company. It is engaged in providing diversified services to the resources, civil infrastructure and urban development sectors. It operates in four segments: Civil, Mining, Action Drill and Blast, and Mining Technologies. The civil segment specializes in the delivery of private and public civil infrastructure, mine development, bulk earthworks and commercial and residential subdivisions. Civil construction projects include roads, bridges, tailings storage facilities, rail formation, ports, water infrastructure and concrete installations. The mining segment specializes in mine management, contract mining, load and haul, dragline operations, coal handling prep plants, maintenance services and the fabrication of water and service vehicles. Action drill & blast is a provider of integrated, end-to-end production drill and blast services to the mining and civil construction sectors. The mining technologies segment offers materials handling design capability.","categories":["Infrastructure"],"logoIdentifier":"93924ab3-fa14-4714-bc62-8e212b8f823e","logos":{"wide":"/api/v1/public/instrument-logo/55c961b6-355a-44ab-bf15-132c6a5c5a09/logo/93924ab3-fa14-4714-bc62-8e212b8f823e/1024/0","thumb":"/api/v1/public/instrument-logo/55c961b6-355a-44ab-bf15-132c6a5c5a09/logo/93924ab3-fa14-4714-bc62-8e212b8f823e/342/0","micro":"/api/v1/public/instrument-logo/55c961b6-355a-44ab-bf15-132c6a5c5a09/logo/93924ab3-fa14-4714-bc62-8e212b8f823e/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.075","percent":"-0.048077","max":"0","min":"0"},"1w":{"value":"-0.135","percent":"-0.083333","max":"1.62","min":"1.56"},"1m":{"value":"-0.055","percent":"-0.035714","max":"1.7","min":"1.56"},"3m":{"value":"-0.695","percent":"-0.318807","max":"2.18","min":"1.54"},"6m":{"value":"-1.425","percent":"-0.489691","max":"3.12","min":"1.54"},"1y":{"value":"-0.415","percent":"-0.218421","max":"3.12","min":"1.54"},"5y":{"value":"1.265","percent":"5.75","max":"3.4","min":"0.195"}},"marketPrice":"1.485","marketLastCheck":"2021-06-16T04:03:24Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"9.63","marketCap":677707000,"websiteUrl":"https://nrw.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#601410","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0513","annualisedReturnPercent":"-0.167121","ceo":"Julian Pemberton","employees":7053},{"id":"527e2bfd-4a25-447f-94da-0b2c534ca3a7","urlSlug":"asx-aqz","instrumentType":"equity","symbol":"AQZ","kidsRecommended":false,"isVolatile":false,"name":"Alliance Aviation Services Ltd","description":"Alliance Aviation Services Limited is an aviation services provider. The Company operates as an air charter operator in Australia, and provides a service various sectors, including tourism, corporate, sporting, entertainment and media, educational, and the government. The Company's primary business is the air transportation of workers and contractors to and from remote projects of mining and energy companies. The Company owns a fleet of approximately 15 Fokker 100 (F100), over eight Fokker 70LR (F70) jet aircraft and approximately five Fokker 50 (F50) turboprops. It has operations and aircraft based in Brisbane, Townsville, Cairns, Adelaide, Melbourne, Perth, Darwin and Auckland. The Company offers inclusive and coordinated air charter services, including the transportation of equipment and personnel both domestically and internationally, for organizations, such as the Australian Defence Force (ADF) and Australian Department of Immigration and Border Protection.","categories":["Transport"],"logoIdentifier":"adea4fc3-09b0-44ee-9522-8c2c5c0bed12","logos":{"wide":"/api/v1/public/instrument-logo/527e2bfd-4a25-447f-94da-0b2c534ca3a7/logo/adea4fc3-09b0-44ee-9522-8c2c5c0bed12/1024/0","thumb":"/api/v1/public/instrument-logo/527e2bfd-4a25-447f-94da-0b2c534ca3a7/logo/adea4fc3-09b0-44ee-9522-8c2c5c0bed12/342/0","micro":"/api/v1/public/instrument-logo/527e2bfd-4a25-447f-94da-0b2c534ca3a7/logo/adea4fc3-09b0-44ee-9522-8c2c5c0bed12/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.02","percent":"0.004762","max":"0","min":"0"},"1w":{"value":"-0.02","percent":"-0.004717","max":"4.24","min":"4.2"},"1m":{"value":"0.03","percent":"0.00716","max":"4.41","min":"4.09"},"3m":{"value":"0.08","percent":"0.019324","max":"4.62","min":"3.92"},"6m":{"value":"0.42","percent":"0.110526","max":"4.62","min":"3.62"},"1y":{"value":"1.2","percent":"0.397351","max":"4.62","min":"2.81"},"5y":{"value":"3.74","percent":"7.791667","max":"4.62","min":"0.48"}},"marketPrice":"4.22","marketLastCheck":"2021-06-16T04:03:05Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"17.74","marketCap":677211000,"websiteUrl":"http://www.allianceairlines.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#67718C","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0174","annualisedReturnPercent":"0.414751","ceo":"Lee Schofield","employees":534},{"id":"351dce12-50d3-49c6-af93-b769c2e68614","urlSlug":"nyse-dco","instrumentType":"equity","symbol":"DCO","kidsRecommended":false,"isVolatile":false,"name":"Ducommun Inc.","description":"Ducommun Incorporated is a global provider of engineering and manufacturing services for various products and failure applications used primarily in the aerospace, defense, industrial, natural resources, medical and other industries. The Company is a solution-based provider, offering a range of value-added products and services in its primary businesses of electronics, structures and integrated solutions. The Company operates through two segments: Electronic Systems (ES) and Structural Systems (SS). The ES has over three product offerings in electronics manufacturing for various applications, including complex cable assemblies and interconnect systems, printed circuit board assemblies, and electronic, electromechanical and mechanical assemblies. The SS segment offers over three product offerings to support a customer base, including commercial aircraft, military fixed-wing aircraft, and military and commercial rotary-wing aircraft.","categories":["Manufacturing","Technology"],"logoIdentifier":"16214457-f387-4d18-a910-e503d2930fd6","logos":{"wide":"/api/v1/public/instrument-logo/351dce12-50d3-49c6-af93-b769c2e68614/logo/16214457-f387-4d18-a910-e503d2930fd6/1024/0","thumb":"/api/v1/public/instrument-logo/351dce12-50d3-49c6-af93-b769c2e68614/logo/16214457-f387-4d18-a910-e503d2930fd6/342/0","micro":"/api/v1/public/instrument-logo/351dce12-50d3-49c6-af93-b769c2e68614/logo/16214457-f387-4d18-a910-e503d2930fd6/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.04","percent":"0.000701","max":"0","min":"0"},"1w":{"value":"1.72","percent":"0.031053","max":"57.32","min":"55.35"},"1m":{"value":"0.83","percent":"0.014748","max":"57.32","min":"50.21"},"3m":{"value":"-0.9","percent":"-0.015515","max":"64.43","min":"50.21"},"6m":{"value":"5.01","percent":"0.096161","max":"64.43","min":"49.34"},"1y":{"value":"20.26","percent":"0.549796","max":"64.43","min":"31.0"},"5y":{"value":"36.97","percent":"1.83565","max":"64.43","min":"16.61"}},"marketPrice":"57.11","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"24.6","marketCap":676256501,"websiteUrl":"www.ducommun.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#6E9AB4","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.549796","ceo":"Stephen Oswald","employees":2700},{"id":"45ec9f98-d551-4a3e-a6ff-0b1946d38d00","urlSlug":"nasdaq-spne","instrumentType":"equity","symbol":"SPNE","kidsRecommended":false,"isVolatile":false,"name":"SeaSpine Holdings Corp","description":"SeaSpine Holdings Corporation is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company offers a portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. Its spinal implants portfolio consists of a line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Orthobiologics products are used in orthopedic and dental procedures and consist of a range of bone graft substitutes to address the key elements of bone regeneration -osteoinduction, osteoconduction and osteogenesis. Spinal implant portfolio consists of a line of products for spinal decompression alignment and stabilization.","categories":["Healthcare","Manufacturing"],"logoIdentifier":"0434da2f-d781-424e-977e-f62662000be1","logos":{"wide":"/api/v1/public/instrument-logo/45ec9f98-d551-4a3e-a6ff-0b1946d38d00/logo/0434da2f-d781-424e-977e-f62662000be1/1024/0","thumb":"/api/v1/public/instrument-logo/45ec9f98-d551-4a3e-a6ff-0b1946d38d00/logo/0434da2f-d781-424e-977e-f62662000be1/342/0","micro":"/api/v1/public/instrument-logo/45ec9f98-d551-4a3e-a6ff-0b1946d38d00/logo/0434da2f-d781-424e-977e-f62662000be1/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.01","percent":"-0.00049","max":"0","min":"0"},"1w":{"value":"0.33","percent":"0.016451","max":"20.4","min":"19.65"},"1m":{"value":"0.72","percent":"0.036604","max":"21.31","min":"19.62"},"3m":{"value":"1.74","percent":"0.093298","max":"22.41","min":"17.19"},"6m":{"value":"3.06","percent":"0.176572","max":"22.41","min":"16.11"},"1y":{"value":"8.94","percent":"0.780786","max":"22.41","min":"9.07"},"5y":{"value":"10.79","percent":"1.123958","max":"22.41","min":"6.08"}},"marketPrice":"20.39","marketLastCheck":"2021-06-15T19:59:44Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":676154482,"websiteUrl":"www.seaspine.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#F8AE82","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.780786","ceo":"Keith Valentine","employees":0},{"id":"35a25505-0ddf-4d8d-8e09-1d7391466433","urlSlug":"nyse-co","instrumentType":"equity","symbol":"CO","kidsRecommended":false,"isVolatile":false,"name":"Global Cord Blood Corp","description":"Global Cord Blood Corporation, formerly China Cord Blood Corporation, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.","categories":["Healthcare"],"logoIdentifier":"2a81424d-344f-47ad-babc-cdb209351802","logos":{"wide":"/api/v1/public/instrument-logo/35a25505-0ddf-4d8d-8e09-1d7391466433/logo/2a81424d-344f-47ad-babc-cdb209351802/1024/0","thumb":"/api/v1/public/instrument-logo/35a25505-0ddf-4d8d-8e09-1d7391466433/logo/2a81424d-344f-47ad-babc-cdb209351802/342/0","micro":"/api/v1/public/instrument-logo/35a25505-0ddf-4d8d-8e09-1d7391466433/logo/2a81424d-344f-47ad-babc-cdb209351802/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.12","percent":"-0.021127","max":"5.77","min":"5.52"},"1m":{"value":"0.56","percent":"0.112","max":"6.22","min":"5.19"},"3m":{"value":"0.89","percent":"0.190578","max":"6.22","min":"4.46"},"6m":{"value":"1.86","percent":"0.502703","max":"6.22","min":"3.55"},"1y":{"value":"2.39","percent":"0.753943","max":"6.22","min":"2.99"},"5y":{"value":"-0.36","percent":"-0.060811","max":"14.67","min":"2.56"}},"marketPrice":"5.56","marketLastCheck":"2021-06-15T19:59:58Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":675823977,"websiteUrl":"www.chinacordbloodcorp.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":null,"pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.753943","ceo":"","employees":1260},{"id":"27d3877e-61c8-4507-9804-12f07e87e198","urlSlug":"nyse-msgn","instrumentType":"equity","symbol":"MSGN","kidsRecommended":false,"isVolatile":false,"name":"MSG Networks Inc","description":"MSG Networks Inc., a pioneer in sports media, owns and operates two award-winning regional sports and entertainment networks and a companion streaming service that serve the nation's number one media market, the New York DMA, as well as other portions of New York, New Jersey, Connecticut and Pennsylvania. The networks feature a wide range of compelling sports content, including exclusive live local games and other programming of the New York Knicks, New York Rangers, New York Islanders, New Jersey Devils and Buffalo Sabres, as well as significant coverage of the New York Giants and Buffalo Bills. This content, in addition to a diverse array of other sporting events and critically acclaimed original programming, has established MSG Networks as the gold standard in regional sports.","categories":["Services"],"logoIdentifier":"c60ff73e-2a6d-418a-9683-c9b8344913ff","logos":{"wide":"/api/v1/public/instrument-logo/27d3877e-61c8-4507-9804-12f07e87e198/logo/c60ff73e-2a6d-418a-9683-c9b8344913ff/1024/0","thumb":"/api/v1/public/instrument-logo/27d3877e-61c8-4507-9804-12f07e87e198/logo/c60ff73e-2a6d-418a-9683-c9b8344913ff/342/0","micro":"/api/v1/public/instrument-logo/27d3877e-61c8-4507-9804-12f07e87e198/logo/c60ff73e-2a6d-418a-9683-c9b8344913ff/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.01","percent":"-0.000643","max":"15.66","min":"15.43"},"1m":{"value":"0.19","percent":"0.01237","max":"15.98","min":"15.03"},"3m":{"value":"-4.9","percent":"-0.239609","max":"20.45","min":"14.8"},"6m":{"value":"2.09","percent":"0.155275","max":"20.61","min":"12.63"},"1y":{"value":"4.37","percent":"0.390877","max":"20.61","min":"8.8"},"5y":{"value":"-1.56","percent":"-0.091175","max":"27.66","min":"8.8"}},"marketPrice":"15.55","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"5.03","marketCap":675801134,"websiteUrl":"www.msgnetworks.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#747474","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.390877","ceo":"Hank Ratner","employees":700},{"id":"6a6a96d0-9cfa-4078-8659-368946d13b06","urlSlug":"nasdaq-ueic","instrumentType":"equity","symbol":"UEIC","kidsRecommended":false,"isVolatile":false,"name":"Universal Electronics Inc.","description":"Universal Electronics Inc. (UEI) develops control and sensor technology solutions and manufactures a line of pre-programmed and universal remote control products, audio-video (AV) accessories, and intelligent wireless security and automation components. The Company's offerings include pre-programmed universal infrared (IR) and radio frequency (RF) remote controls that are sold primarily to subscription broadcasting providers, original equipment manufacturers (OEMs), retailers, and private label customers, and integrated circuits, on which its software and universal device control database is embedded, sold primarily to OEMs, subscription broadcasting providers, and private label customers. Its offerings also include software, firmware and technology solutions that enable devices, such as televisions, set-top boxes, stereos, smart phones tablets, gaming controllers and other consumer electronic devices, to wirelessly connect and interact with home networks and interactive services.","categories":["Manufacturing"],"logoIdentifier":"47a9bfb0-0ba6-451c-9af9-e799ee3f0a0c","logos":{"wide":"/api/v1/public/instrument-logo/6a6a96d0-9cfa-4078-8659-368946d13b06/logo/47a9bfb0-0ba6-451c-9af9-e799ee3f0a0c/1024/0","thumb":"/api/v1/public/instrument-logo/6a6a96d0-9cfa-4078-8659-368946d13b06/logo/47a9bfb0-0ba6-451c-9af9-e799ee3f0a0c/342/0","micro":"/api/v1/public/instrument-logo/6a6a96d0-9cfa-4078-8659-368946d13b06/logo/47a9bfb0-0ba6-451c-9af9-e799ee3f0a0c/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.01","percent":"-0.000204","max":"0","min":"0"},"1w":{"value":"-1.15","percent":"-0.02289","max":"50.24","min":"48.92"},"1m":{"value":"2.44","percent":"0.052304","max":"51.84","min":"47.51"},"3m":{"value":"-12.61","percent":"-0.204376","max":"61.7","min":"46.5"},"6m":{"value":"-3.81","percent":"-0.072023","max":"64.23","min":"46.5"},"1y":{"value":"1.8","percent":"0.038063","max":"64.23","min":"35.46"},"5y":{"value":"-19.47","percent":"-0.283985","max":"78.99","min":"24.04"}},"marketPrice":"49.09","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"17.53","marketCap":675700287,"websiteUrl":"www.uei.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#744C4C","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.038063","ceo":"Paul Arling","employees":4347},{"id":"8b8e8cbe-5b8d-4bcc-82be-98477681a193","urlSlug":"nyse-cldt","instrumentType":"equity","symbol":"CLDT","kidsRecommended":false,"isVolatile":false,"name":"Chatham Lodging Trust","description":"Chatham Lodging Trust is a real estate investment trust. The Company invests primarily in upscale extended-stay and premium-branded select-service hotels. All of the Company's assets are held by, and all of its operations are conducted through Chatham Lodging, L.P. (the Operating Partnership). The Company owns over 42 hotels with an aggregate of 6,283 rooms located in 15 states and the District of Columbia. The Company's hotels included upscale extended-stay hotels that operate under the Residence Inn by Marriott brand and Homewood Suites by Hilton brand, as well as premium-branded select-service hotels that operate under the Courtyard by Marriott brand, the Hampton Inn or Hampton Inn and Suites by Hilton brand, the Hilton Garden Inn by Hilton brand, the SpringHill Suites by Marriott brand and the Hyatt Place brand.","categories":["Banking and finance","Property"],"logoIdentifier":"18da913e-2fd1-489f-aa4d-e39971397c03","logos":{"wide":"/api/v1/public/instrument-logo/8b8e8cbe-5b8d-4bcc-82be-98477681a193/logo/18da913e-2fd1-489f-aa4d-e39971397c03/1024/0","thumb":"/api/v1/public/instrument-logo/8b8e8cbe-5b8d-4bcc-82be-98477681a193/logo/18da913e-2fd1-489f-aa4d-e39971397c03/342/0","micro":"/api/v1/public/instrument-logo/8b8e8cbe-5b8d-4bcc-82be-98477681a193/logo/18da913e-2fd1-489f-aa4d-e39971397c03/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.04","percent":"-0.002872","max":"13.93","min":"13.71"},"1m":{"value":"0.92","percent":"0.070933","max":"13.97","min":"12.78"},"3m":{"value":"-0.33","percent":"-0.023207","max":"14.47","min":"12.09"},"6m":{"value":"2.31","percent":"0.199482","max":"14.67","min":"10.46"},"1y":{"value":"6.39","percent":"0.852","max":"14.67","min":"5.16"},"5y":{"value":"-7.4","percent":"-0.347581","max":"24.56","min":"3.76"}},"marketPrice":"13.89","marketLastCheck":"2021-06-15T19:59:58Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-14.33","marketCap":675302881,"websiteUrl":"www.chathamlodgingtrust.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":null,"pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.852","ceo":"","employees":39},{"id":"b6f369a6-214c-4f4f-aee3-ecaf61a5a4a3","urlSlug":"nyse-ccx","instrumentType":"equity","symbol":"SKIL","kidsRecommended":false,"isVolatile":false,"name":"Skillsoft Corporation Class A","description":"Skillsoft Corporation is a global leader in corporate digital learning. They are focused on helping organisations build a future-fit workforce, skilled and ready for the jobs of tomorrow. Skillsoft serves a blue-chip enterprise customer base that includes approximately 70% of the Fortune 1000, customers in over 160 countries and more than 45 million learners globally. Skillsoft’s solutions are an advantage for the entire enterprise, enabling organisations to overcome critical skill gaps and drive demonstrable behaviour change while generating return on income (ROI) at scale.","categories":["Technology"],"logoIdentifier":"a57f121a-d0d0-4945-8c0b-5f0198570221","logos":{"wide":"/api/v1/public/instrument-logo/b6f369a6-214c-4f4f-aee3-ecaf61a5a4a3/logo/a57f121a-d0d0-4945-8c0b-5f0198570221/1024/0","thumb":"/api/v1/public/instrument-logo/b6f369a6-214c-4f4f-aee3-ecaf61a5a4a3/logo/a57f121a-d0d0-4945-8c0b-5f0198570221/342/0","micro":"/api/v1/public/instrument-logo/b6f369a6-214c-4f4f-aee3-ecaf61a5a4a3/logo/a57f121a-d0d0-4945-8c0b-5f0198570221/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.39","percent":"-0.038348","max":"11.61","min":"9.78"},"1m":{"value":"-0.25","percent":"-0.024925","max":"11.61","min":"9.78"},"3m":{"value":"-0.26","percent":"-0.025896","max":"11.61","min":"9.78"},"6m":{"value":"-0.37","percent":"-0.036453","max":"11.61","min":"9.78"},"1y":{"value":"-1.12","percent":"-0.102752","max":"11.61","min":"9.78"},"5y":null},"marketPrice":"9.78","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":674820000,"websiteUrl":"","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#116084","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.102752","ceo":"","employees":0},{"id":"a5d17ddd-0215-4f26-85c3-9d051e71cd00","urlSlug":"nyse-avk","instrumentType":"equity","symbol":"AVK","kidsRecommended":false,"isVolatile":false,"name":"Advent Convertible and Income Fund","description":"Advent Convertible and Income Fund, formerly Advent Claymore Convertible Securities and Income Fund, is a diversified, closed-end management investment company. The Fund's investment objective is to provide total return through a combination of capital appreciation and current income. Under normal market conditions, the Fund invests approximately 80% of its managed assets in a diversified portfolio of convertible securities and non-convertible income securities. Under normal market conditions, the Fund will invest approximately 30% of its managed assets in convertible securities and may invest up to 70% of its managed assets in non-convertible income securities. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, financial and basic materials. The investment advisor of the Fund is Advent Capital Management, LLC, which specializes in convertible and high-yield securities for institutional and individual investors.","categories":["Banking and finance"],"logoIdentifier":"dacad5f8-b1a5-492f-8f3e-be20aac1c039","logos":{"wide":"/api/v1/public/instrument-logo/a5d17ddd-0215-4f26-85c3-9d051e71cd00/logo/dacad5f8-b1a5-492f-8f3e-be20aac1c039/1024/0","thumb":"/api/v1/public/instrument-logo/a5d17ddd-0215-4f26-85c3-9d051e71cd00/logo/dacad5f8-b1a5-492f-8f3e-be20aac1c039/342/0","micro":"/api/v1/public/instrument-logo/a5d17ddd-0215-4f26-85c3-9d051e71cd00/logo/dacad5f8-b1a5-492f-8f3e-be20aac1c039/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.04","percent":"0.002047","max":"0","min":"0"},"1w":{"value":"0.32","percent":"0.016615","max":"19.58","min":"19.03"},"1m":{"value":"1.33","percent":"0.072877","max":"19.6","min":"18.22"},"3m":{"value":"2.18","percent":"0.125287","max":"19.6","min":"17.13"},"6m":{"value":"3.31","percent":"0.203442","max":"19.6","min":"16.27"},"1y":{"value":"6.47","percent":"0.493516","max":"19.6","min":"12.79"},"5y":{"value":"5.79","percent":"0.419869","max":"19.6","min":"8.04"}},"marketPrice":"19.58","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":674622838,"websiteUrl":"www.guggenheiminvestments.com/cef/fund/avk","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#80938A","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.06920853787663876","annualisedReturnPercent":"0.5627245378766388","ceo":"Tracy Maitland","employees":0},{"id":"a1e6e56c-ead7-4118-b5d5-9d955d86c5da","urlSlug":"nyse-bzh","instrumentType":"equity","symbol":"BZH","kidsRecommended":false,"isVolatile":false,"name":"Beazer Homes USA Inc.","description":"Beazer Homes USA, Inc. is a geographically diversified homebuilder. As of September 30, 2016, the Company had operations in 13 states within over three geographic regions in the United States. The Company's segments include West, East and Southeast. The Company markets and sells its products through its Website, www.beazer.com; mobile site, m.beazer.com; real estate listing sites, online advertising, including search engine marketing and display advertising, social media, video, brochures, direct marketing and out-of-home advertising, including billboards and signage, as well as other activities. It offers lender choice and personalization. The Company's Choice Plans allows buyers to choose living areas, such as the kitchen and master bathroom. Its West segment includes Arizona, California, Nevada and Texas. Its East segment includes Indiana, Maryland/Delaware, Tennessee and Virginia. Its Southeast segment includes Florida, Georgia, North Carolina and South Carolina.","categories":["Manufacturing","Property"],"logoIdentifier":"68bcdc05-bfc0-499c-9a05-3fd49134986b","logos":{"wide":"/api/v1/public/instrument-logo/a1e6e56c-ead7-4118-b5d5-9d955d86c5da/logo/68bcdc05-bfc0-499c-9a05-3fd49134986b/1024/0","thumb":"/api/v1/public/instrument-logo/a1e6e56c-ead7-4118-b5d5-9d955d86c5da/logo/68bcdc05-bfc0-499c-9a05-3fd49134986b/342/0","micro":"/api/v1/public/instrument-logo/a1e6e56c-ead7-4118-b5d5-9d955d86c5da/logo/68bcdc05-bfc0-499c-9a05-3fd49134986b/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.03","percent":"0.001393","max":"0","min":"0"},"1w":{"value":"-0.53","percent":"-0.023993","max":"22.09","min":"20.98"},"1m":{"value":"-2.27","percent":"-0.095258","max":"24.0","min":"20.98"},"3m":{"value":"0.91","percent":"0.044068","max":"25.31","min":"19.26"},"6m":{"value":"6.47","percent":"0.428761","max":"25.31","min":"14.65"},"1y":{"value":"10.59","percent":"0.96536","max":"25.31","min":"9.23"},"5y":{"value":"14.4","percent":"2.011173","max":"25.31","min":"4.63"}},"marketPrice":"21.56","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"8.58","marketCap":673762813,"websiteUrl":"www.beazer.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#BF9586","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.96536","ceo":"Allan Merrill","employees":1100},{"id":"8d388ca4-6702-4fcf-8deb-2b6095e86364","urlSlug":"nasdaq-pets","instrumentType":"equity","symbol":"PETS","kidsRecommended":false,"isVolatile":false,"name":"Petmed Express, Inc.","description":"PetMed Express, Inc. (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies. Its products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. It also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties. These pet supplies include food, beds, crates, stairs, strollers and other pet supplies. Its products included Non-Prescription Medications (Over the Counter (OTC)) and supplies, and Prescription Medications (Rx). Its customers are located in California, Florida, Texas, New York, Virginia and Georgia, among others.","categories":["Retail"],"logoIdentifier":"817d4808-33ca-4306-9fe2-4c638ec9ebfc","logos":{"wide":"/api/v1/public/instrument-logo/8d388ca4-6702-4fcf-8deb-2b6095e86364/logo/817d4808-33ca-4306-9fe2-4c638ec9ebfc/1024/0","thumb":"/api/v1/public/instrument-logo/8d388ca4-6702-4fcf-8deb-2b6095e86364/logo/817d4808-33ca-4306-9fe2-4c638ec9ebfc/342/0","micro":"/api/v1/public/instrument-logo/8d388ca4-6702-4fcf-8deb-2b6095e86364/logo/817d4808-33ca-4306-9fe2-4c638ec9ebfc/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.08","percent":"-0.002409","max":"0","min":"0"},"1w":{"value":"-1.58","percent":"-0.04552","max":"34.71","min":"32.75"},"1m":{"value":"4.64","percent":"0.162864","max":"46.06","min":"27.82"},"3m":{"value":"-1.89","percent":"-0.053969","max":"46.06","min":"27.73"},"6m":{"value":"1.29","percent":"0.040515","max":"51.8","min":"27.73"},"1y":{"value":"-2.72","percent":"-0.075872","max":"51.8","min":"27.73"},"5y":{"value":"14.94","percent":"0.82133","max":"53.24","min":"15.01"}},"marketPrice":"33.13","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"21.8","marketCap":671522340,"websiteUrl":"www.1800petmeds.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#855A56","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.03302626305430972","annualisedReturnPercent":"-0.04284573694569028","ceo":"Menderes Akdag","employees":214},{"id":"e0d099f7-98c3-44e2-b45a-c8ec60c40ec7","urlSlug":"nasdaq-anab","instrumentType":"equity","symbol":"ANAB","kidsRecommended":false,"isVolatile":false,"name":"AnaptysBio Inc","description":"AnaptysBio, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology. The Company develops its product candidates using its antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product pipeline includes ANB020 and ANB019, which are being developed to treat severe inflammatory disorders with unmet medical need. The Company's ANB020 product candidate is an antibody that inhibits the activity of interleukin-33, and is used for the treatment of severe adult asthma and severe adult peanut allergy. In addition, the Company is engaged in developing its ANB019 product candidate, an antibody that inhibits the interleukin-36 receptor, for the treatment of rare inflammatory diseases called generalized pustular psoriasis (GPP) and palmoplantar pustular psoriasis (PPP).","categories":["Healthcare","Manufacturing","Technology"],"logoIdentifier":"99180203-c361-499e-8bd0-2c071bd2e644","logos":{"wide":"/api/v1/public/instrument-logo/e0d099f7-98c3-44e2-b45a-c8ec60c40ec7/logo/99180203-c361-499e-8bd0-2c071bd2e644/1024/0","thumb":"/api/v1/public/instrument-logo/e0d099f7-98c3-44e2-b45a-c8ec60c40ec7/logo/99180203-c361-499e-8bd0-2c071bd2e644/342/0","micro":"/api/v1/public/instrument-logo/e0d099f7-98c3-44e2-b45a-c8ec60c40ec7/logo/99180203-c361-499e-8bd0-2c071bd2e644/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.04","percent":"0.001633","max":"0","min":"0"},"1w":{"value":"0.52","percent":"0.021658","max":"24.89","min":"24.01"},"1m":{"value":"-1.57","percent":"-0.060153","max":"25.92","min":"22.8"},"3m":{"value":"3.83","percent":"0.185024","max":"26.16","min":"19.82"},"6m":{"value":"0.86","percent":"0.036333","max":"35.23","min":"19.0"},"1y":{"value":"5.31","percent":"0.276275","max":"35.23","min":"14.17"},"5y":null},"marketPrice":"24.53","marketLastCheck":"2021-06-15T19:59:57Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-22.5","marketCap":671366451,"websiteUrl":"www.anaptysbio.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#2E8BAE","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.276275","ceo":"Hamza Suria","employees":0},{"id":"ede3cda4-0754-46e1-97b9-830f9fd823b7","urlSlug":"nyse-tmst","instrumentType":"equity","symbol":"TMST","kidsRecommended":false,"isVolatile":false,"name":"TimkenSteel Corp","description":"TimkenSteel Corporation manufactures alloy steel, as well as carbon and micro-alloy steel. The Company's portfolio includes special bar quality (SBQ) bars, seamless mechanical tubing and precision steel components. In addition, the Company supplies machining and thermal treatment services, as well as manage raw material recycling programs, which are used as a feeder system for its melt operations. The Company's products include SBQ Steel and Seamless Mechanical Steel Tubing, and Value-added Precision Products and Services. Its focus is on alloy steel. The Company manufactures carbon, micro-alloy and alloy steel, sold as ingots, bars and tubes. In addition to its customized steels, the Company also manufactures custom-make precision components. Its products and services are used in a range of demanding applications in the market sectors, such as oil and gas, industrial equipment, mining and power generation.","categories":["Manufacturing","Mining, oil and gas"],"logoIdentifier":"c36b9f90-175e-42c7-92e5-cd3590561f18","logos":{"wide":"/api/v1/public/instrument-logo/ede3cda4-0754-46e1-97b9-830f9fd823b7/logo/c36b9f90-175e-42c7-92e5-cd3590561f18/1024/0","thumb":"/api/v1/public/instrument-logo/ede3cda4-0754-46e1-97b9-830f9fd823b7/logo/c36b9f90-175e-42c7-92e5-cd3590561f18/342/0","micro":"/api/v1/public/instrument-logo/ede3cda4-0754-46e1-97b9-830f9fd823b7/logo/c36b9f90-175e-42c7-92e5-cd3590561f18/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.02","percent":"-0.001364","max":"0","min":"0"},"1w":{"value":"-1.05","percent":"-0.066922","max":"15.99","min":"14.66"},"1m":{"value":"0.3","percent":"0.020921","max":"15.99","min":"13.99"},"3m":{"value":"4.08","percent":"0.386364","max":"15.99","min":"9.6"},"6m":{"value":"9.64","percent":"1.928","max":"15.99","min":"4.65"},"1y":{"value":"10.2","percent":"2.297297","max":"15.99","min":"3.49"},"5y":{"value":"4.99","percent":"0.517098","max":"22.84","min":"2.26"}},"marketPrice":"14.64","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-21.72","marketCap":669999090,"websiteUrl":"www.timkensteel.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#596D8F","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"2.297297","ceo":"Terry Dunlap","employees":2500},{"id":"89e9b09b-5926-4c88-9b9c-64f26e0d535c","urlSlug":"nyse-manu","instrumentType":"equity","symbol":"MANU","kidsRecommended":false,"isVolatile":false,"name":"Manchester United Plc.","description":"Manchester United plc is engaged in the operation of a professional football club together with related and ancillary activities. Its football operations primarily comprise various activities, such as its first team, reserve team, youth academy, global scouting networks and other operations, such as its sport science, medical and fitness operations at the Aon Training Complex. It operates in three sectors, including Commercial, Broadcasting and Matchday. Within the Commercial revenue sector, the Company monetizes its global brand through approximately three revenue streams, such as sponsorship; retail, merchandising, apparel and product licensing, and mobile and content. It monetizes the value of its global brand and community of followers through marketing and sponsorship relationships with international and regional companies around the world. It markets and sells sports apparel, training and leisure wear and other clothing featuring the Manchester United brand on a global basis.","categories":["Services"],"logoIdentifier":"b33493a8-4664-44f1-a4cd-f79f8ac26c0d","logos":{"wide":"/api/v1/public/instrument-logo/89e9b09b-5926-4c88-9b9c-64f26e0d535c/logo/b33493a8-4664-44f1-a4cd-f79f8ac26c0d/1024/0","thumb":"/api/v1/public/instrument-logo/89e9b09b-5926-4c88-9b9c-64f26e0d535c/logo/b33493a8-4664-44f1-a4cd-f79f8ac26c0d/342/0","micro":"/api/v1/public/instrument-logo/89e9b09b-5926-4c88-9b9c-64f26e0d535c/logo/b33493a8-4664-44f1-a4cd-f79f8ac26c0d/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.000647","max":"0","min":"0"},"1w":{"value":"-0.18","percent":"-0.011502","max":"15.75","min":"15.46"},"1m":{"value":"-0.33","percent":"-0.020886","max":"15.99","min":"15.46"},"3m":{"value":"-3.41","percent":"-0.180614","max":"18.88","min":"15.34"},"6m":{"value":"-1.19","percent":"-0.071429","max":"20.13","min":"14.41"},"1y":{"value":"-0.67","percent":"-0.041512","max":"20.13","min":"13.32"},"5y":{"value":"-1.17","percent":"-0.070313","max":"26.2","min":"12.55"}},"marketPrice":"15.47","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":668360227,"websiteUrl":"www.manutd.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#E2AD60","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.005806451843630883","annualisedReturnPercent":"-0.035705548156369116","ceo":"","employees":0},{"id":"30786d81-5e5e-4e58-b723-a43d2694c172","urlSlug":"nasdaq-clnn","instrumentType":"equity","symbol":"CLNN","kidsRecommended":false,"isVolatile":false,"name":"Clene Inc","description":"Clene is a clinical-stage biopharmaceutical company focused on the development of unique therapeutics for neurodegenerative diseases. Clene has innovated a novel nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. Clene has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. Founded in 2013, the company is based in Salt Lake City, Utah with R&D and manufacturing operations located in North East, Maryland.","categories":["Technology"],"logoIdentifier":"bef0cd0e-4529-4b46-81a1-4dbf954b11c6","logos":{"wide":"/api/v1/public/instrument-logo/30786d81-5e5e-4e58-b723-a43d2694c172/logo/bef0cd0e-4529-4b46-81a1-4dbf954b11c6/1024/0","thumb":"/api/v1/public/instrument-logo/30786d81-5e5e-4e58-b723-a43d2694c172/logo/bef0cd0e-4529-4b46-81a1-4dbf954b11c6/342/0","micro":"/api/v1/public/instrument-logo/30786d81-5e5e-4e58-b723-a43d2694c172/logo/bef0cd0e-4529-4b46-81a1-4dbf954b11c6/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.07","percent":"-0.006239","max":"0","min":"0"},"1w":{"value":"-0.86","percent":"-0.071607","max":"12.01","min":"11.14"},"1m":{"value":"3.85","percent":"0.527397","max":"12.01","min":"8.59"},"3m":{"value":"-2.26","percent":"-0.168531","max":"14.22","min":"6.98"},"6m":null,"1y":null,"5y":null},"marketPrice":"11.15","marketLastCheck":"2021-06-15T19:59:50Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":664254359,"websiteUrl":"clene.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#7D9DBD","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":null,"ceo":"","employees":0},{"id":"390a246a-ccef-4910-904d-d15358986f26","urlSlug":"nyse-vvr","instrumentType":"equity","symbol":"VVR","kidsRecommended":false,"isVolatile":false,"name":"Invesco Senior Income Trust","description":"Invesco Senior Income Trust is a diversified, closed-end management investment company. The Trust's investment objective is to provide a high level of current income, consistent with preservation of capital. The Trust invests primarily in a portfolio of interests in floating or variable senior loans to corporations, partnerships and other entities, which operate in a range of industries and geographic regions. It borrows money for investment purposes, which may create the opportunity for enhanced return, but also should be considered a speculative technique and may increase the Trust's volatility. It invests in various sectors, including electronics/electrical; business equipment and services; telecommunications; cable and satellite television; retailers (except food and drug); healthcare; chemicals and plastics; utilities, and lodging and casinos. Invesco Advisers, Inc. is the investment advisor of the Trust. Invesco Senior Secured Management, Inc. is the sub-advisor of the trust.","categories":["Banking and finance"],"logoIdentifier":"fdde8471-44ef-4aa0-b6c7-1d85ce27d9ad","logos":{"wide":"/api/v1/public/instrument-logo/390a246a-ccef-4910-904d-d15358986f26/logo/fdde8471-44ef-4aa0-b6c7-1d85ce27d9ad/1024/0","thumb":"/api/v1/public/instrument-logo/390a246a-ccef-4910-904d-d15358986f26/logo/fdde8471-44ef-4aa0-b6c7-1d85ce27d9ad/342/0","micro":"/api/v1/public/instrument-logo/390a246a-ccef-4910-904d-d15358986f26/logo/fdde8471-44ef-4aa0-b6c7-1d85ce27d9ad/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.04","percent":"0.009302","max":"4.34","min":"4.3"},"1m":{"value":"0.12","percent":"0.028436","max":"4.34","min":"4.21"},"3m":{"value":"0.17","percent":"0.040767","max":"4.34","min":"4.17"},"6m":{"value":"0.45","percent":"0.115681","max":"4.34","min":"3.86"},"1y":{"value":"0.82","percent":"0.232955","max":"4.34","min":"3.39"},"5y":{"value":"0.18","percent":"0.043269","max":"4.76","min":"1.9"}},"marketPrice":"4.34","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":664153394,"websiteUrl":"","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#707CE7","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.05580446884692219","annualisedReturnPercent":"0.28875946884692216","ceo":"","employees":0},{"id":"ef15c454-dfce-4cd4-8eb2-b88b14e2f163","urlSlug":"nasdaq-cass","instrumentType":"equity","symbol":"CASS","kidsRecommended":false,"isVolatile":false,"name":"Cass Information Systems Inc","description":"Cass Information Systems, Inc. (Cass) is a provider of payment and information processing services to manufacturing, distribution and retail enterprises across the United States with operating locations in Missouri, Ohio, Massachusetts, South Carolina and Florida. The Company provides transportation invoice rating, payment processing, auditing, accounting and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility related expenses. The Company operates in two segments: Information Services and Banking Services. The Information Services segment provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations. The Banking Services segment provides banking services primarily to privately held businesses and churches. The Company, through its bank subsidiary, Cass Commercial Bank (the Bank), provides commercial banking services.","categories":["Services","Technology"],"logoIdentifier":"f94841f9-f939-449b-9cd4-bab5ccc20ec5","logos":{"wide":"/api/v1/public/instrument-logo/ef15c454-dfce-4cd4-8eb2-b88b14e2f163/logo/f94841f9-f939-449b-9cd4-bab5ccc20ec5/1024/0","thumb":"/api/v1/public/instrument-logo/ef15c454-dfce-4cd4-8eb2-b88b14e2f163/logo/f94841f9-f939-449b-9cd4-bab5ccc20ec5/342/0","micro":"/api/v1/public/instrument-logo/ef15c454-dfce-4cd4-8eb2-b88b14e2f163/logo/f94841f9-f939-449b-9cd4-bab5ccc20ec5/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.06","percent":"-0.001305","max":"0","min":"0"},"1w":{"value":"0.09","percent":"0.001965","max":"46.06","min":"45.78"},"1m":{"value":"0.16","percent":"0.003498","max":"46.29","min":"43.99"},"3m":{"value":"-1.81","percent":"-0.037938","max":"47.82","min":"43.99"},"6m":{"value":"3.0","percent":"0.06993","max":"48.0","min":"37.88"},"1y":{"value":"5.6","percent":"0.138958","max":"48.0","min":"35.51"},"5y":{"value":"-4.34","percent":"-0.086385","max":"74.44","min":"29.35"}},"marketPrice":"45.9","marketLastCheck":"2021-06-15T19:59:43Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"27.0","marketCap":661001723,"websiteUrl":"www.cassinfo.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#779CC3","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.02332351931794665","annualisedReturnPercent":"0.16228151931794665","ceo":"Eric Brunngraber","employees":0},{"id":"07ebfae1-d546-4f20-9025-27f29684cabc","urlSlug":"nasdaq-pdfs","instrumentType":"equity","symbol":"PDFS","kidsRecommended":false,"isVolatile":false,"name":"PDF Solutions Inc.","description":"PDF Solutions, Inc. is a provider of infrastructure technologies and services for integrated circuits (IC). The Company's technologies and services focus on the IC manufacturing process life cycle. It operates in the segment of licensing and implementation of yield improvement solutions for integrated circuit manufacturers. The Company's solutions combine software, test chips, an electrical wafer test system, methodologies and professional services. The Company has developed solutions for yield simulation, analysis, loss detection, and improvement. Its characterization vehicle infrastructure (CVi) enables customers to electrically characterize the manufacturing process, and establish fail-rate information needed to calibrate manufacturing yield models and prioritize yield improvement activities. Its Exensio YieldAware solution combines software and services to enable customers to collect and combine product test data and equipment signals during production.","categories":["Services","Technology"],"logoIdentifier":"1025d201-20a2-4923-b199-0b6a1dbbf5bb","logos":{"wide":"/api/v1/public/instrument-logo/07ebfae1-d546-4f20-9025-27f29684cabc/logo/1025d201-20a2-4923-b199-0b6a1dbbf5bb/1024/0","thumb":"/api/v1/public/instrument-logo/07ebfae1-d546-4f20-9025-27f29684cabc/logo/1025d201-20a2-4923-b199-0b6a1dbbf5bb/342/0","micro":"/api/v1/public/instrument-logo/07ebfae1-d546-4f20-9025-27f29684cabc/logo/1025d201-20a2-4923-b199-0b6a1dbbf5bb/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.38","percent":"0.021714","max":"17.88","min":"17.5"},"1m":{"value":"0.47","percent":"0.026996","max":"18.07","min":"17.1"},"3m":{"value":"-0.32","percent":"-0.017582","max":"19.63","min":"16.64"},"6m":{"value":"-4.53","percent":"-0.202142","max":"23.22","min":"16.64"},"1y":{"value":"-0.6","percent":"-0.032468","max":"26.18","min":"16.64"},"5y":{"value":"3.71","percent":"0.261821","max":"26.18","min":"7.73"}},"marketPrice":"17.88","marketLastCheck":"2021-06-15T19:59:58Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-13.34","marketCap":660304395,"websiteUrl":"www.pdf.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#99B2CF","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"-0.032468","ceo":"John Kibarian","employees":325},{"id":"daf528ce-3cfb-481d-8d97-805e558ae4b1","urlSlug":"asx-spl","instrumentType":"equity","symbol":"SPL","kidsRecommended":false,"isVolatile":false,"name":"Starpharma Holdings Limited","description":"Starpharma Holdings Limited is engaged in development of dendrimer products for pharmaceutical, life science and other applications. The Company utilizes dendrimers, which is a type of synthetic nanoscale polymer that is regular in size and structure and suited to pharmaceutical and medical uses. The Company’s development programs, including VivaGel portfolio and DEP drug delivery. The Company’s DEP drug delivery, which includes DEP docetaxel, DEP cabazitaxel, DEP irinotecan and Targeted-DEP. It develops and commercializes dendrimer nanotechnology across various applications, including sexual health, drug delivery for pharmaceuticals, animal health, coatings and inks, crop protection, diagnostics and research reagents, cosmetics and water treatment. Its products are based on VivaGel (SPL7013, astodrimer sodium), a dendrimer, which has antimicrobial properties. It has both partnered and internal programs in drug delivery.","categories":["Manufacturing","Healthcare"],"logoIdentifier":"e3c1c6e2-267e-4df9-9f3a-a6068588fc88","logos":{"wide":"/api/v1/public/instrument-logo/daf528ce-3cfb-481d-8d97-805e558ae4b1/logo/e3c1c6e2-267e-4df9-9f3a-a6068588fc88/1024/0","thumb":"/api/v1/public/instrument-logo/daf528ce-3cfb-481d-8d97-805e558ae4b1/logo/e3c1c6e2-267e-4df9-9f3a-a6068588fc88/342/0","micro":"/api/v1/public/instrument-logo/daf528ce-3cfb-481d-8d97-805e558ae4b1/logo/e3c1c6e2-267e-4df9-9f3a-a6068588fc88/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.045","percent":"-0.026946","max":"0","min":"0"},"1w":{"value":"-0.02","percent":"-0.012158","max":"1.725","min":"1.645"},"1m":{"value":"0.02","percent":"0.012461","max":"1.79","min":"1.61"},"3m":{"value":"-0.345","percent":"-0.175127","max":"2.15","min":"1.605"},"6m":{"value":"0.185","percent":"0.128472","max":"2.49","min":"1.425"},"1y":{"value":"0.565","percent":"0.533019","max":"2.49","min":"1.03"},"5y":{"value":"0.925","percent":"1.321429","max":"2.49","min":"0.605"}},"marketPrice":"1.625","marketLastCheck":"2021-06-16T04:03:30Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":659877000,"websiteUrl":"http://www.starpharma.com","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#44788C","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"0.533019","ceo":"Jacinth Fairley","employees":49},{"id":"b5c0b43c-35d1-4e4e-b564-f2d801ff8d7f","urlSlug":"asx-sxy","instrumentType":"equity","symbol":"SXY","kidsRecommended":false,"isVolatile":false,"name":"Senex Energy Ltd","description":"Senex Energy Limited (Senex) is an oil and gas exploration and production company. The Company's segments include SURAT/BOWEN BASIN and COOPER/EROMANGA BASINS. The Company produces over one million barrels of oil annually from over 10 Senex-operated oil fields. The Company holds an acreage position across the South Australian and Queensland Cooper Basin, with approximately 15,000 square kilometers considered prospective for conventional and unconventional (tight) oil. The Company holds various interests, including the western flank of the Cooper Basin, as well as north, south and east of the Moomba processing and transportation hub. In the northern Cooper Basin, Senex is developing its Vanessa conventional gas field. Its Western Surat Gas Project is involved in the extraction of natural gas from coal seams over approximately 910 square kilometers of Senex permits, north of Roma in Queensland.","categories":["Mining, oil and gas"],"logoIdentifier":"154a9cc9-467c-420a-b869-18acc5617653","logos":{"wide":"/api/v1/public/instrument-logo/b5c0b43c-35d1-4e4e-b564-f2d801ff8d7f/logo/154a9cc9-467c-420a-b869-18acc5617653/1024/0","thumb":"/api/v1/public/instrument-logo/b5c0b43c-35d1-4e4e-b564-f2d801ff8d7f/logo/154a9cc9-467c-420a-b869-18acc5617653/342/0","micro":"/api/v1/public/instrument-logo/b5c0b43c-35d1-4e4e-b564-f2d801ff8d7f/logo/154a9cc9-467c-420a-b869-18acc5617653/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.16","percent":"0.046647","max":"0","min":"0"},"1w":{"value":"0.07","percent":"0.019886","max":"3.53","min":"3.43"},"1m":{"value":"0.65","percent":"0.221088","max":"3.53","min":"2.9"},"3m":{"value":"3.21","percent":"8.447368","max":"3.53","min":"0.36"},"6m":{"value":"3.265","percent":"10.046154","max":"3.53","min":"0.305"},"1y":{"value":"3.335","percent":"13.078431","max":"3.53","min":"0.215"},"5y":{"value":"3.315","percent":"12.054545","max":"3.53","min":"0.13"}},"marketPrice":"3.59","marketLastCheck":"2021-06-16T04:03:29Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":659542000,"websiteUrl":"https://www.senexenergy.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#44798F","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0117","annualisedReturnPercent":"13.090131","ceo":"Ian Davies","employees":191},{"id":"5b1a315b-4e70-44e2-8c26-a78fd5242132","urlSlug":"nyse-tcs","instrumentType":"equity","symbol":"TCS","kidsRecommended":false,"isVolatile":false,"name":"Container Store Group Inc","description":"The Container Store Group, Inc. is a specialty retailer of storage and organization products. The Company's segments include The Container Store (TCS), Elfa and Corporate/Other. The Company's TCS segment consists of its retail stores, Website and call center, as well as its installation and organizational services business. The Company's Elfa segment includes the manufacturing business that produces the elfa brand products that are sold domestically, exclusively through the TCS segment, as well as throughout Europe. Its Swedish subsidiary, Elfa International AB (Elfa), designs and manufactures component-based shelving and drawer systems and made-to-measure sliding doors. It merchandises over 11,000 products in each of its stores and online. Its stores are organized into various lifestyle departments, which include Bath, Box, Closets, Collections, Containers, Custom Closets, Food Storage, Gift Packaging, Hooks, Kitchen, Laundry, Office, Shelving, Storage, Trash and Travel.","categories":["Food and drink","Retail"],"logoIdentifier":"c947940c-c733-488a-bcf6-bcf8a5dec829","logos":{"wide":"/api/v1/public/instrument-logo/5b1a315b-4e70-44e2-8c26-a78fd5242132/logo/c947940c-c733-488a-bcf6-bcf8a5dec829/1024/0","thumb":"/api/v1/public/instrument-logo/5b1a315b-4e70-44e2-8c26-a78fd5242132/logo/c947940c-c733-488a-bcf6-bcf8a5dec829/342/0","micro":"/api/v1/public/instrument-logo/5b1a315b-4e70-44e2-8c26-a78fd5242132/logo/c947940c-c733-488a-bcf6-bcf8a5dec829/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.000766","max":"0","min":"0"},"1w":{"value":"-0.76","percent":"-0.054993","max":"13.85","min":"13.05"},"1m":{"value":"-0.47","percent":"-0.034738","max":"13.97","min":"11.65"},"3m":{"value":"-4.34","percent":"-0.249425","max":"17.8","min":"11.65"},"6m":{"value":"2.48","percent":"0.234405","max":"19.19","min":"9.54"},"1y":{"value":"9.7","percent":"2.886905","max":"19.19","min":"2.99"},"5y":{"value":"8.42","percent":"1.814655","max":"19.19","min":"1.99"}},"marketPrice":"13.06","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"11.15","marketCap":658913840,"websiteUrl":"www.containerstore.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#639CCB","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"2.886905","ceo":"Melissa Reiff","employees":5110},{"id":"39918e5b-097e-4f03-8764-987ea3eb6552","urlSlug":"asx-ehe","instrumentType":"equity","symbol":"EHE","kidsRecommended":false,"isVolatile":false,"name":"Estia Health Ltd","description":"Estia Health Ltd is an Australia-based company that is engaged in the provision of services in residential aged care homes in Australia. It provides services across approximately 69 homes in New South Wales, Queensland, South Australia and Victoria. It offers various general activities, such as gardening, reading, movies, music, parties, cultural celebrations, art sessions or daytrips, lifestyle coordinators can also cater for specialist interests. Its clinical care services include regular reviews and includes daily medication; pain management programs; medical services, such physiotherapy, pharmacy, podiatry, optometry and dental; specialist dementia care and personal care. It operates its homes across various locations, such as Albany Creek, Albury, Aldgate, Altona Meadows, Ardeer, Bendigo, Camden, Burton, Daw Park and Figtree.","categories":["Healthcare"],"logoIdentifier":"b54d2fba-10eb-4521-a6b0-36d50ec59640","logos":{"wide":"/api/v1/public/instrument-logo/39918e5b-097e-4f03-8764-987ea3eb6552/logo/b54d2fba-10eb-4521-a6b0-36d50ec59640/1024/0","thumb":"/api/v1/public/instrument-logo/39918e5b-097e-4f03-8764-987ea3eb6552/logo/b54d2fba-10eb-4521-a6b0-36d50ec59640/342/0","micro":"/api/v1/public/instrument-logo/39918e5b-097e-4f03-8764-987ea3eb6552/logo/b54d2fba-10eb-4521-a6b0-36d50ec59640/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.06","percent":"-0.023256","max":"0","min":"0"},"1w":{"value":"0.04","percent":"0.016129","max":"2.58","min":"2.48"},"1m":{"value":"-0.09","percent":"-0.034483","max":"2.7","min":"2.47"},"3m":{"value":"0.49","percent":"0.241379","max":"2.7","min":"2.0"},"6m":{"value":"0.775","percent":"0.444126","max":"2.7","min":"1.67"},"1y":{"value":"1.085","percent":"0.756098","max":"2.7","min":"1.275"},"5y":{"value":"-1.850058","percent":"-0.423349","max":"4.994352","min":"0.905"}},"marketPrice":"2.52","marketLastCheck":"2021-06-16T04:03:11Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":658463000,"websiteUrl":"http://www.estiahealth.com.au","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#607B8D","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0209","annualisedReturnPercent":"0.776998","ceo":"Ian Thorley","employees":7500},{"id":"544cdee0-56e8-46c0-9f55-cace54c51389","urlSlug":"nyse-aspn","instrumentType":"equity","symbol":"ASPN","kidsRecommended":false,"isVolatile":false,"name":"Aspen Aerogels Inc","description":"Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions. Its product lines include Pyrogel and Cryogel. The Company provides Pyrogel XT/XT-E that reduces the risk of corrosion under insulation in high temperature operating systems; Pyrogel XTF, which provides protection against fire; Cryogel Z, which is designed for sub-ambient and cryogenic applications in the energy infrastructure market, and Spaceloft Subsea, which is used in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft for use in building and construction market, and Cryogel X201, which is used in cold system designs consisting of refrigerated appliances, cold storage equipment and aerospace systems.","categories":["Manufacturing","Property","Services","Transport"],"logoIdentifier":"01162a17-73f6-4259-a39c-cad6ff1e8930","logos":{"wide":"/api/v1/public/instrument-logo/544cdee0-56e8-46c0-9f55-cace54c51389/logo/01162a17-73f6-4259-a39c-cad6ff1e8930/1024/0","thumb":"/api/v1/public/instrument-logo/544cdee0-56e8-46c0-9f55-cace54c51389/logo/01162a17-73f6-4259-a39c-cad6ff1e8930/342/0","micro":"/api/v1/public/instrument-logo/544cdee0-56e8-46c0-9f55-cace54c51389/logo/01162a17-73f6-4259-a39c-cad6ff1e8930/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.000431","max":"0","min":"0"},"1w":{"value":"1.16","percent":"0.05256","max":"23.22","min":"21.52"},"1m":{"value":"5.15","percent":"0.284845","max":"23.22","min":"17.96"},"3m":{"value":"2.32","percent":"0.110952","max":"23.22","min":"16.92"},"6m":{"value":"6.97","percent":"0.428659","max":"26.0","min":"15.79"},"1y":{"value":"15.87","percent":"2.15625","max":"26.0","min":"5.93"},"5y":{"value":"19.1","percent":"4.624697","max":"26.0","min":"1.61"}},"marketPrice":"23.23","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":658293316,"websiteUrl":"www.aerogel.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#949BA6","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"2.15625","ceo":"","employees":0},{"id":"d7d935c3-b87e-4fe5-8398-0db2dd0eda70","urlSlug":"nasdaq-atlc","instrumentType":"equity","symbol":"ATLC","kidsRecommended":false,"isVolatile":false,"name":"Atlanticus Holdings Corp","description":"Atlanticus Holdings Corporation is focused on providing financial services. Through its subsidiaries, the Company offers an array of financial products and services. The Company operates through two segments: Credit and Other Investments, and Auto Finance. The Company's Credit and Other Investments segment includes its point-of-sale and direct-to-consumer finance operations, investments in and servicing of its various credit card receivables portfolios and other product development and limited investment in consumer finance technology platforms that capitalize on its credit infrastructure. The Company's Auto Finance segment operations are principally conducted through its CAR platform, which purchases and services loans secured by automobiles from or for a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business. The Company also provides loan servicing activities.","categories":["Banking and finance"],"logoIdentifier":"a69a60c8-9a57-4f98-bc3b-a429774f8665","logos":{"wide":"/api/v1/public/instrument-logo/d7d935c3-b87e-4fe5-8398-0db2dd0eda70/logo/a69a60c8-9a57-4f98-bc3b-a429774f8665/1024/0","thumb":"/api/v1/public/instrument-logo/d7d935c3-b87e-4fe5-8398-0db2dd0eda70/logo/a69a60c8-9a57-4f98-bc3b-a429774f8665/342/0","micro":"/api/v1/public/instrument-logo/d7d935c3-b87e-4fe5-8398-0db2dd0eda70/logo/a69a60c8-9a57-4f98-bc3b-a429774f8665/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.33","percent":"0.008425","max":"40.0","min":"37.98"},"1m":{"value":"9.76","percent":"0.328178","max":"40.0","min":"32.79"},"3m":{"value":"10.0","percent":"0.338983","max":"40.0","min":"26.19"},"6m":{"value":"19.27","percent":"0.952546","max":"40.0","min":"20.23"},"1y":{"value":"25.76","percent":"1.874818","max":"40.0","min":"7.82"},"5y":{"value":"36.73","percent":"13.259928","max":"40.0","min":"1.63"}},"marketPrice":"39.5","marketLastCheck":"2021-06-15T19:50:38Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"7.1","marketCap":657290547,"websiteUrl":"www.atlanticus.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#05374C","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"1.874818","ceo":"","employees":0},{"id":"6e7d4026-f291-413a-823b-8215f6edae10","urlSlug":"nyse-ldl","instrumentType":"equity","symbol":"LDL","kidsRecommended":false,"isVolatile":false,"name":"Lydall, Inc.","description":"Lydall, Inc. designs and manufactures specialty engineered filtration media, industrial thermal insulating solutions, automotive thermal and acoustical barriers for filtration/separation and thermal/acoustical applications. The Company's segments are Performance Materials, Technical Nonwovens, Thermal/Acoustical Metals and Thermal/Acoustical Fibers. The Performance Materials segment includes filtration, thermal insulation and life sciences filtration businesses. The Technical Nonwovens segment includes its industrial filtration and advanced materials products. The Thermal/Acoustical Metals segment includes its metal parts and related tooling used in automotive applications. The Thermal/Acoustical Fibers segment includes its fiber parts business and related tooling used in automotive applications. Its Filtration products include LydAir MG (Micro-Glass) Air Filtration Media, LydAir MB (Melt Blown) Air Filtration Media and Arioso Membrane Composite Media.","categories":["Manufacturing"],"logoIdentifier":"0bcb1c50-fed7-46d3-8847-ee59eb34ddaa","logos":{"wide":"/api/v1/public/instrument-logo/6e7d4026-f291-413a-823b-8215f6edae10/logo/0bcb1c50-fed7-46d3-8847-ee59eb34ddaa/1024/0","thumb":"/api/v1/public/instrument-logo/6e7d4026-f291-413a-823b-8215f6edae10/logo/0bcb1c50-fed7-46d3-8847-ee59eb34ddaa/342/0","micro":"/api/v1/public/instrument-logo/6e7d4026-f291-413a-823b-8215f6edae10/logo/0bcb1c50-fed7-46d3-8847-ee59eb34ddaa/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"-0.2","percent":"-0.005456","max":"36.66","min":"35.9"},"1m":{"value":"-1.13","percent":"-0.030061","max":"37.84","min":"34.7"},"3m":{"value":"-1.61","percent":"-0.042291","max":"39.21","min":"30.96"},"6m":{"value":"4.79","percent":"0.151247","max":"40.93","min":"29.08"},"1y":{"value":"21.8","percent":"1.48704","max":"40.93","min":"11.59"},"5y":{"value":"-1.35","percent":"-0.035705","max":"64.2","min":"5.09"}},"marketPrice":"36.46","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-52.31","marketCap":656972558,"websiteUrl":"www.lydall.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":null,"pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"1.48704","ceo":"Sara Greenstein","employees":3250},{"id":"65a75c99-ef83-471f-b3cb-412770e92bde","urlSlug":"asx-mny","instrumentType":"equity","symbol":"MNY","kidsRecommended":false,"isVolatile":false,"name":"Money3 Corporation Limited","description":"Money3 Corporation Limited is an Australia-based company that provides non-banking credit service. The Company is focused on the provision of automotive finance in Australia and New Zealand. The Company specializes in providing flexible secured and unsecured personal loans to customers. The Company offers secured automotive loans for periods up to 60 months; unsecured personal loans for terms greater than 12 months (larger amount longer term loans), and unsecured personal loans for terms under 12 months. Its brands include Money3, Cash Train and Personal Finance Co.","categories":["Banking and finance"],"logoIdentifier":"7acd2251-b602-45ba-9b66-89de3a509ad9","logos":{"wide":"/api/v1/public/instrument-logo/65a75c99-ef83-471f-b3cb-412770e92bde/logo/7acd2251-b602-45ba-9b66-89de3a509ad9/1024/0","thumb":"/api/v1/public/instrument-logo/65a75c99-ef83-471f-b3cb-412770e92bde/logo/7acd2251-b602-45ba-9b66-89de3a509ad9/342/0","micro":"/api/v1/public/instrument-logo/65a75c99-ef83-471f-b3cb-412770e92bde/logo/7acd2251-b602-45ba-9b66-89de3a509ad9/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.02","percent":"-0.006349","max":"0","min":"0"},"1w":{"value":"-0.02","percent":"-0.006349","max":"3.16","min":"3.11"},"1m":{"value":"0.17","percent":"0.057432","max":"3.25","min":"2.87"},"3m":{"value":"0.23","percent":"0.07931","max":"3.27","min":"2.8"},"6m":{"value":"0.43","percent":"0.159259","max":"3.27","min":"2.66"},"1y":{"value":"1.51","percent":"0.932099","max":"3.27","min":"1.52"},"5y":{"value":"2.15","percent":"2.193878","max":"3.27","min":"0.81"}},"marketPrice":"3.13","marketLastCheck":"2021-06-16T04:03:23Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"22.31","marketCap":653155000,"websiteUrl":"https://www.money3.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#4DC298","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.019","annualisedReturnPercent":"0.951099","ceo":"Scott Baldwin","employees":351},{"id":"5ed49136-53dd-4f20-a619-9f5a83c98fe2","urlSlug":"nasdaq-fnch","instrumentType":"equity","symbol":"FNCH","kidsRecommended":false,"isVolatile":false,"name":"Finch Therapeutics Group Inc","description":"Finch Therapeutics Group, Inc. is a clinical-stage microbiome therapeutics company. The Company leveraging Human-First Discovery platform to develop a class of orally administered biological drugs. It is developing therapeutics designed to deliver missing microbes and their clinically relevant biochemical functions to correct dysbiosis and the diseases that emerge from it. The Company’s Human-First Discovery platform uses reverse translation to identify diseases of dysbiosis and to design microbiome therapeutics that address them. Its lead product candidate, CP101, delivers a complete microbiome and is being developed initially for the treatment of patients with recurrent Clostridioides difficile infection (CDI). It is also advancing CP101 for the treatment of chronic hepatitis B virus (HBV) Its product pipeline includes FIN-524, FIN-525, and FIN-211. ","categories":["Technology"],"logoIdentifier":"d7cef235-0b8c-450c-a45b-c4ec376a12b8","logos":{"wide":"/api/v1/public/instrument-logo/5ed49136-53dd-4f20-a619-9f5a83c98fe2/logo/d7cef235-0b8c-450c-a45b-c4ec376a12b8/1024/0","thumb":"/api/v1/public/instrument-logo/5ed49136-53dd-4f20-a619-9f5a83c98fe2/logo/d7cef235-0b8c-450c-a45b-c4ec376a12b8/342/0","micro":"/api/v1/public/instrument-logo/5ed49136-53dd-4f20-a619-9f5a83c98fe2/logo/d7cef235-0b8c-450c-a45b-c4ec376a12b8/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.0","percent":"0.0","max":"0","min":"0"},"1w":{"value":"0.32","percent":"0.023792","max":"13.77","min":"13.22"},"1m":{"value":"1.73","percent":"0.143688","max":"15.4","min":"12.92"},"3m":null,"6m":null,"1y":null,"5y":null},"marketPrice":"13.77","marketLastCheck":"2021-06-15T19:59:50Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":652975879,"websiteUrl":"finchtherapeutics.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#627171","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":null,"ceo":"","employees":0},{"id":"182460be-77b0-4d07-b18c-64cd4d5525f3","urlSlug":"asx-nto","instrumentType":"equity","symbol":"NTO","kidsRecommended":false,"isVolatile":false,"name":"Nitro Software Ltd","description":"Nitro Software Ltd is an Australia-based technology company. The Company is focused on developing easy-to-use desktop and cloud-based solutions that offers e-signing solutions and the ability to create, convert, combine, edit, sign and share portable document format (PDF) files and documents. The Company’s offered products portfolio include Nitro Productivity Suite, Nitro Pro and Nitro Cloud. ","categories":["Technology"],"logoIdentifier":"8f1a1b0b-3448-430c-86b6-a05c451cbe5c","logos":{"wide":"/api/v1/public/instrument-logo/182460be-77b0-4d07-b18c-64cd4d5525f3/logo/8f1a1b0b-3448-430c-86b6-a05c451cbe5c/1024/0","thumb":"/api/v1/public/instrument-logo/182460be-77b0-4d07-b18c-64cd4d5525f3/logo/8f1a1b0b-3448-430c-86b6-a05c451cbe5c/342/0","micro":"/api/v1/public/instrument-logo/182460be-77b0-4d07-b18c-64cd4d5525f3/logo/8f1a1b0b-3448-430c-86b6-a05c451cbe5c/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.01","percent":"-0.003049","max":"0","min":"0"},"1w":{"value":"0.13","percent":"0.041401","max":"3.31","min":"3.14"},"1m":{"value":"0.66","percent":"0.252874","max":"3.31","min":"2.61"},"3m":{"value":"0.59","percent":"0.220149","max":"3.31","min":"2.44"},"6m":{"value":"0.22","percent":"0.072131","max":"3.33","min":"2.26"},"1y":{"value":"1.84","percent":"1.286713","max":"3.58","min":"1.42"},"5y":null},"marketPrice":"3.27","marketLastCheck":"2021-06-16T04:03:24Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"0.0","marketCap":651884000,"websiteUrl":null,"exchange":"ASX","legacyImageUrl":null,"dominantColour":"#874C30","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"1.286713","ceo":null,"employees":132},{"id":"eda1ebba-d191-48b2-ba20-7770fef048b0","urlSlug":"asx-sig","instrumentType":"equity","symbol":"SIG","kidsRecommended":false,"isVolatile":false,"name":"Sigma Healthcare Ltd","description":"Sigma Healthcare Limited, formerly Sigma Pharmaceuticals Limited, is engaged in pharmacy wholesale and distribution business. The Company operates over 1,200 branded and independent stores, including pharmacy retail brands, such as Amcal, Guardian, PharmaSave, Chemist King and Discount Drug Stores. It has partnership agreements to provide independent pharmacy support services to more than 500 independent pharmacies. Its Sigma Financial Services provide support services to help pharmacies better manage their finances; offers pharmacy finance referral program, and pharmacy fit-out finance with tailored bank support. The Company also operates online store to offer approximately 9,000 products to consumers. It also operates Sigma Generics Program (SGP) to drive generic substitution and pharmacist profitability. It also operates Sigma Resource Centre to provide customizable levels of support to suit the needs of all pharmacies, branded or independent.","categories":["Healthcare"],"logoIdentifier":"7c2eb20b-1b94-4c0c-9947-a972ddbdaf38","logos":{"wide":"/api/v1/public/instrument-logo/eda1ebba-d191-48b2-ba20-7770fef048b0/logo/7c2eb20b-1b94-4c0c-9947-a972ddbdaf38/1024/0","thumb":"/api/v1/public/instrument-logo/eda1ebba-d191-48b2-ba20-7770fef048b0/logo/7c2eb20b-1b94-4c0c-9947-a972ddbdaf38/342/0","micro":"/api/v1/public/instrument-logo/eda1ebba-d191-48b2-ba20-7770fef048b0/logo/7c2eb20b-1b94-4c0c-9947-a972ddbdaf38/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"-0.005","percent":"-0.008065","max":"0","min":"0"},"1w":{"value":"-0.005","percent":"-0.008065","max":"0.62","min":"0.615"},"1m":{"value":"-0.02","percent":"-0.031496","max":"0.66","min":"0.61"},"3m":{"value":"-0.065","percent":"-0.095588","max":"0.725","min":"0.58"},"6m":{"value":"0.0","percent":"0.0","max":"0.73","min":"0.58"},"1y":{"value":"0.0","percent":"0.0","max":"0.73","min":"0.515"},"5y":{"value":"-0.6","percent":"-0.493827","max":"1.51","min":"0.405"}},"marketPrice":"0.615","marketLastCheck":"2021-06-16T04:03:29Z","tradingStatus":"active","exchangeCountry":"aus","peRatio":"10.16","marketCap":651455000,"websiteUrl":"https://sigmahealthcare.com.au/","exchange":"ASX","legacyImageUrl":null,"dominantColour":"#B99494","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0161","annualisedReturnPercent":"0.0161","ceo":"Mark Hooper","employees":156},{"id":"06b44911-a31a-4ddf-b36c-c4df82c60f88","urlSlug":"nasdaq-clsk","instrumentType":"equity","symbol":"CLSK","kidsRecommended":false,"isVolatile":false,"name":"Cleanspark Inc","description":"CleanSpark, Inc., a Nevada corporation, is in the business of providing advanced software and controls technology solutions to solve modern energy challenges. We have a suite of software solutions that provide end-to-end microgrid energy modeling, energy market communications, and energy management solutions. Our offerings consist of intelligent energy monitoring and controls, intelligent microgrid design software, middleware communications protocols for the energy industry, energy system engineering, and software consulting services.\r \r Through its wholly owned subsidiary ATL Data Centers LLC, CleanSpark owns and operates a data center that provides customers with traditional on-site and cloud-based data center services. The Company also owns and operates a fleet of over 3,400 ASIC (application-specific integrated circuit) Bitcoin miners producing over 200 PH/s in mining capacity. Capacity is expected to increase to over 300 PH/s in mining capacity in early 2021. CleanSpark plans to apply its technologies with a goal of mining bitcoins at the lowest energy prices in the United States .","categories":["Services","Technology"],"logoIdentifier":"a460ef48-163f-4bea-bc08-1d24a0758541","logos":{"wide":"/api/v1/public/instrument-logo/06b44911-a31a-4ddf-b36c-c4df82c60f88/logo/a460ef48-163f-4bea-bc08-1d24a0758541/1024/0","thumb":"/api/v1/public/instrument-logo/06b44911-a31a-4ddf-b36c-c4df82c60f88/logo/a460ef48-163f-4bea-bc08-1d24a0758541/342/0","micro":"/api/v1/public/instrument-logo/06b44911-a31a-4ddf-b36c-c4df82c60f88/logo/a460ef48-163f-4bea-bc08-1d24a0758541/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.03","percent":"0.001568","max":"0","min":"0"},"1w":{"value":"0.28","percent":"0.014831","max":"19.7","min":"18.26"},"1m":{"value":"3.47","percent":"0.22116","max":"19.7","min":"14.66"},"3m":{"value":"-3.52","percent":"-0.155203","max":"24.4","min":"13.84"},"6m":{"value":"2.63","percent":"0.159105","max":"40.39","min":"13.84"},"1y":{"value":"16.89","percent":"7.440529","max":"40.39","min":"2.02"},"5y":{"value":"14.06","percent":"2.756863","max":"40.39","min":"1.05"}},"marketPrice":"19.16","marketLastCheck":"2021-06-15T19:59:42Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"0","marketCap":650755701,"websiteUrl":"cleanspark.com","exchange":"NASDAQ","legacyImageUrl":null,"dominantColour":"#1C6D83","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"7.440529","ceo":"","employees":0},{"id":"a22583e2-697c-4bad-b246-4ff6ebe85aa6","urlSlug":"nyse-chs","instrumentType":"equity","symbol":"CHS","kidsRecommended":false,"isVolatile":false,"name":"Chico`s Fas, Inc.","description":"Chico's FAS, Inc. is an omni-channel specialty retailer of women's private branded, casual-to-dressy clothing, intimates and accessories, operating under the Chico's, White House Black Market (WHBM) and Soma brand names. The Company is also engaged in the sale of merchandise in its domestic and international retail stores. The Chico's brand sells private branded clothing focusing on women 45 and older. Chico's apparel includes the Black Label, Zenergy and Travelers collections. The WHBM brand sells private branded clothing focusing on women 35 and older. WHBM sells clothing and accessory items, including everyday basics, wear-to-work, denim and occasion. It offers black and white color palette. The accessories at WHBM include shoes, belts, scarves, handbags and jewelry. The Soma brand sells private branded lingerie, sleepwear, loungewear, activewear and beauty products focusing on women 35 and older. The lingerie category includes bras, panties, shapewear and swimwear.","categories":["Retail"],"logoIdentifier":"bc1613c7-6252-4d72-8a75-43279246c939","logos":{"wide":"/api/v1/public/instrument-logo/a22583e2-697c-4bad-b246-4ff6ebe85aa6/logo/bc1613c7-6252-4d72-8a75-43279246c939/1024/0","thumb":"/api/v1/public/instrument-logo/a22583e2-697c-4bad-b246-4ff6ebe85aa6/logo/bc1613c7-6252-4d72-8a75-43279246c939/342/0","micro":"/api/v1/public/instrument-logo/a22583e2-697c-4bad-b246-4ff6ebe85aa6/logo/bc1613c7-6252-4d72-8a75-43279246c939/171/0"},"riskRating":7,"comparisonPrices":{"1d":{"value":"0.01","percent":"0.00189","max":"0","min":"0"},"1w":{"value":"-0.31","percent":"-0.055258","max":"5.75","min":"5.29"},"1m":{"value":"1.09","percent":"0.258907","max":"6.3","min":"4.02"},"3m":{"value":"1.75","percent":"0.492958","max":"6.3","min":"2.81"},"6m":{"value":"3.71","percent":"2.333333","max":"6.3","min":"1.49"},"1y":{"value":"3.78","percent":"2.486842","max":"6.3","min":"0.92"},"5y":{"value":"-5.51","percent":"-0.509713","max":"16.7","min":"0.92"}},"marketPrice":"5.3","marketLastCheck":"2021-06-15T19:59:59Z","tradingStatus":"active","exchangeCountry":"usa","peRatio":"-3.23","marketCap":648562602,"websiteUrl":"chicosfas.com","exchange":"NYSE","legacyImageUrl":null,"dominantColour":"#494648","pdsDriveId":null,"assetManager":null,"fixedFeeSpread":null,"managementFeePercent":null,"grossDividendYieldPercent":"0.0","annualisedReturnPercent":"2.486842","ceo":"Molly Langenstein","employees":18500}]}